Skip to main content Skip to main menu
UF Health University of Florida
Florida Center for Brain Tumor Research University of Florida

Publications

2020 Publications

he following articles were published in 2020 and were written by research faculty at Florida partner institutions or collaborators who are members of FCBTR. The listing is from PubMed which is a free resource that is developed and maintained by the National Center for Biotechnology Information (NCBI), at the U.S. National Library of Medicine (NLM), located at the National Institutes of Health (NIH). Institutions included here are University of Florida, University of Miami, Mayo Clinic, Florida, Moffitt Cancer Center, and Cleveland Clinic, Florida.

Please use the drop down menu to see the publications for each institution.

University of Florida
  • January – March  
    • Rose M, Duhamel M, Aboulouard S, Kobeissy F, Le Rhun E, Desmons A, Tierny D,Fournier I, Rodet F, Salzet M. The Role of a Proprotein Convertase Inhibitor in Reactivation of Tumor-Associated Macrophages and Inhibition of Glioma Growth. MolTher Oncolytics. 2020 Mar 31;17:31-46. doi: 10.1016/j.omto.2020.03.005.e Collection 2020 Jun 26. PubMed PMID: 32300641; PubMed Central PMCID: PMC7152595.
    • Audette MA, Bordas SPA, Blatt JE. Robotically Steered Needles: A Survey of Neurosurgical Applications and Technical Innovations. Robot Surg. 2020 Mar19;7:1-23. doi: 10.2147/RSRR.S224446. eCollection 2020. Review. PubMed PMID:32258180; PubMed Central PMCID: PMC7090177.
    • Milano MT, Bates JE, Budnik J, Qiu H, Hardy S, Cummings MA, Baumgart MA, Maggiore RJ, Mulford DA, Usuki KY. Risk of brain metastases in T1-3N0 NSCLC: a population-based analysis. Lung Cancer Manag. 2020 Feb 25;9(1):LMT25. doi:10.2217/lmt-2019-0010. PubMed PMID: 32256710; PubMed Central PMCID: PMC7110582.
    • von Roemeling CA, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, Yang Z, Yang M, Deng W, Bruno KA, Chan CK, Lee AS, Rosenfeld SS, Yun K, Johnson AJ, Mitchell DA, Jiang W, Kim BYS. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020 Mar 20;11(1):1508.doi: 10.1038/s41467-020-15129-8. PubMed PMID: 32198351; PubMed Central PMCID:PMC7083893.
    • Peacock SH, Grek AA, Rogers ER, Freeman WD, White LJ, Li Z, Hartjes T, Naessens JM. Neuro R(2) score: Predicting high-risk neurologic readmissions within 30 days. Neurology. 2020 Apr 14;94(15):e1614-e1621. doi:10.1212/WNL.0000000000009252. Epub 2020 Mar 13. PubMed PMID: 32170035.
    • Murgoci AN, Duhamel M, Raffo-Romero A, Mallah K, Aboulouard S, Lefebvre C, Kobeissy F, Fournier I, Zilkova M, Maderova D, Cizek M, Cizkova D, Salzet M. Location of neonatal microglia drives small extracellular vesicles content and biological functions in vitro. J Extracell Vesicles. 2020 Feb 18;9(1):1727637.doi: 10.1080/20013078.2020.1727637. eCollection 2020. PubMed PMID: 32158520;PubMed Central PMCID: PMC7049881.
    • Tran AD, Fogarty G, Nowak AK, Diaby V, Hong A, Watts C, Morton RL. Cost-Effectiveness of Subsequent Whole-Brain Radiotherapy or Hippocampal-Avoidant Whole-Brain Radiotherapy Versus Stereotactic Radiosurgery or Surgery Alone for Treatment of Melanoma Brain Metastases. Appl Health Econ Health Policy. 2020 Mar 11. doi: 10.1007/s40258-020-00560-1. [Epub ahead of print] PubMed PMID: 32157631.
    • Rutenberg MS, Rotondo RL, Rao D, Holtzman AL, Indelicato DJ, Huh S, Morris CG, Mendenhall WM. Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study. J Neurooncol. 2020Apr;147(2):387-395. doi: 10.1007/s11060-020-03432-9. Epub 2020 Feb 21. PubMedPMID: 32086697.
    • Flores-Toro JA, Luo D, Gopinath A, Sarkisian MR, Campbell JJ, Charo IF, Singh R, Schall TJ, Datta M, Jain RK, Mitchell DA, Harrison JK. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas. Proc Natl Acad Sci U S A. 2020 Jan14;117(2):1129-1138. doi: 10.1073/pnas.1910856117. Epub 2019 Dec 26. PubMed PMID:31879345; PubMed Central PMCID: PMC6969504.
    • Liu APY, Gudenas B, Lin T, Orr BA, Klimo P Jr, Kumar R, Bouffet E, Gururangan S, Crawford JR, Kellie SJ, Chintagumpala M, Fisher MJ, Bowers DC, Hassall T, Indelicato DJ, Onar-Thomas A, Ellison DW, Boop FA, Merchant TE, Robinson GW, Northcott PA, Gajjar A. Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathol. 2020Feb;139(2):273-275. doi: 10.1007/s00401-019-02115-8. PubMed PMID: 31865440.
    • handra V, Agarwal N, Zenonos GA, Zhang X, Hamilton RL, Gardner PA. Concomitant parasagittal meningioma and adjacent intracranial abscess of occult etiology. J Clin Neurosci. 2020 Feb;72:474-480. doi: 10.1016/j.jocn.2019.11.033. Epub 2019 Dec 18. PubMed PMID: 31864828.
    • Vlasak AL, Shin DH, Kubilis PS, Roper SN, Karachi A, Hoh BL, Rahman M. Comparing Standard Performance and Outcome Measures in Hospitalized Pituitary Tumor Patients with Secretory versus Nonsecretory Tumors. World Neurosurg. 2020Mar;135:e510-e519. doi: 10.1016/j.wneu.2019.12.059. Epub 2019 Dec 19. PubMedPMID: 31863896.
    • Li BK, Vasiljevic A, Dufour C, Yao F, Ho BLB, Lu M, Hwang EI, Gururangan S, Hansford JR, Fouladi M, Nobusawa S, Laquerriere A, Delisle MB, Fangusaro J, Forest F, Toledano H, Solano-Paez P, Leary S, Birks D, Hoffman LM, Szathmari A, Faure-Conter C, Fan X, Catchpoole D, Zhou L, Schultz KAP, Ichimura K, Gauchotte G, Jabado N, Jones C, Loussouarn D, Mokhtari K, Rousseau A, Ziegler DS, Tanaka S, Pomeroy SL, Gajjar A, Ramaswamy V, Hawkins C, Grundy RG, Hill DA, Bouffet E, Huang A, Jouvet A. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study. Acta Neuropathol. 2020 Feb;139(2):223-241. doi:10.1007/s00401-019-02111-y. Epub 2019 Dec 9. PubMed PMID: 31820118.
    • Liu APY, Gudenas B, Lin T, Orr BA, Klimo P Jr, Kumar R, Bouffet E, Gururangan S, Crawford JR, Kellie SJ, Chintagumpala M, Fisher MJ, Bowers DC, Hassall T, Indelicato DJ, Onar-Thomas A, Ellison DW, Boop FA, Merchant TE, Robinson GW, Northcott PA, Gajjar A. Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathol. 2020 Feb;139(2):259-271.doi: 10.1007/s00401-019-02106-9. Epub 2019 Dec 4. Erratum in: Acta Neuropathol.2019 Dec 21;:. PubMed PMID: 31802236; PubMed Central PMCID: PMC7065912.
    • Long Y, Tao H, Karachi A, Grippin AJ, Jin L, Chang YE, Zhang W, Dyson KA, Hou AY, Na M, Deleyrolle LP, Sayour EJ, Rahman M, Mitchell DA, Lin Z, Huang J. Dysregulation of Glutamate Transport Enhances Treg Function That Promotes VEGF Blockade Resistance in Glioblastoma. Cancer Res. 2020 Feb 1;80(3):499-509. doi:10.1158/0008-5472.CAN-19-1577. Epub 2019 Nov 13. PubMed PMID: 31723000.
    • Balis FM, Busch CM, Desai AV, Hibbitts E, Naranjo A, Bagatell R, Irwin M, Fox E. The ganglioside G(D2) as a circulating tumor biomarker for neuroblastoma. Pediatr Blood Cancer. 2020 Jan;67(1):e28031. doi: 10.1002/pbc.28031. Epub 2019Oct 14. PubMed PMID: 31612589.
    • Lawell MP, Indelicato DJ, Paulino AC, Hartsell W, Laack NN, Ermoian RP, Perentesis JP, Vatner R, Perkins S, Mangona VS, Hill-Kayser CE, Wolden SL, Kwok Y, Chang JH, Wilkinson JB, MacEwan I, Chang AL, Eaton BR, Ladra MM, Gallotto SL, Weyman EA, Bajaj BVM, Baliga S, Yeap BY, Berrington de Gonzalez A, Yock TI. An open invitation to join the Pediatric Proton/Photon Consortium Registry to standardize data collection in pediatric radiation oncology. Br J Radiol. 2020Mar;93(1107):20190673. doi: 10.1259/bjr.20190673. Epub 2019 Nov 1. PubMed PMID:31600082; PubMed Central PMCID: PMC7066966.
    • Toussaint L, Indelicato DJ, Muren LP, Li Z, Lassen-Ramshad Y, Kirby K, Pedro C, Mikkelsen R, Di Pinto M, Høyer M, Stokkevåg CH.Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma. Radiother Oncol. 2020 Jan;142:140-146. doi:10.1016/j.radonc.2019.08.002. Epub 2019 Aug 28. PubMed PMID: 31472997.
  • April- June 
    • Mooney MA, Abolfotoh M, Bi WL, Tavanaiepour D, Almefty RO, Bassiouni H, Pravdenkova S, Dunn IF, Al-Mefty O. Is Falcine Meningioma a Diffuse Disease of the Falx? Case Series and Analysis of a “Grade Zero” Resection. Neurosurgery. 2020 Apr 15:nyaa038. doi: 10.1093/neuros/nyaa038. Epub ahead of print. PMID: 32294205.
    • Badr CE, Silver DJ, Siebzehnrubl FA, Deleyrolle LP. Metabolic heterogeneity and adaptability in brain tumors. Cell Mol Life Sci. 2020 Jun 6. doi: 10.1007/s00018-020-03569-w. Epub ahead of print. PMID: 32506168.
    • Laurent D, Freedman R, Cope L, Sacks P, Abbatematteo J, Kubilis P, Bova F, Rahman M. Impact of Extent of Resection on Incidence of Postoperative Complications in Patients With Glioblastoma. Neurosurgery. 2020 May 1;86(5):625-630. doi: 10.1093/neuros/nyz313. PMID: 31342060.
    • Al-Awadhi FH, Salvador-Reyes LA, Elsadek LA, Ratnayake R, Chen QY, Luesch H. Largazole is a Brain-Penetrant Class I HDAC Inhibitor with Extended Applicability to Glioblastoma and CNS Diseases. ACS Chem Neurosci. 2020 Jul 1;11(13):1937-1943. doi: 10.1021/acschemneuro.0c00093. Epub 2020 Jun 19. PMID: 32559056.
    • Audette MA, Bordas SPA, Blatt JE. Robotically Steered Needles: A Survey of Neurosurgical Applications and Technical Innovations. Robot Surg. 2020 Mar 19;7:1-23. doi: 10.2147/RSRR.S224446. PMID: 32258180; PMCID: PMC7090177.
    • Medikonda R, Dunn G, Rahman M, Fecci P, Lim M. A review of glioblastoma immunotherapy. J Neurooncol. 2020 Apr 6. doi: 10.1007/s11060-020-03448-1. Epub ahead of print. PMID: 32253714.
    • Peacock SH, Grek AA, Rogers ER, Freeman WD, White LJ, Li Z, Hartjes T, Naessens JM. Neuro R2 score: Predicting high-risk neurologic readmissions within 30 days. Neurology. 2020 Apr 14;94(15):e1614-e1621. doi: 10.1212/WNL.0000000000009252. Epub 2020 Mar 13. PMID: 32170035.
    • Jones T, Zhang B, Major S, Webb A. All-trans retinoic acid eluting poly(diolcitrate) wafers for treatment of glioblastoma. J Biomed Mater Res B Appl Biomater. 2020 Apr;108(3):619-628. doi: 10.1002/jbm.b.34416. Epub 2019 May 14. PMID: 31087625.
    • Rutenberg MS, Rotondo RL, Rao D, Holtzman AL, Indelicato DJ, Huh S, Morris CG, Mendenhall WM. Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study. J Neurooncol. 2020 Apr;147(2):387-395. doi: 10.1007/s11060-020-03432-9. Epub 2020 Feb 21. PMID: 32086697.

    • Schraw JM, Desrosiers TA, Nembhard WN, Langlois PH, Meyer RE, Canfield MA, Rasmussen SA, Chambers TM, Spector LG, Plon SE, Lupo PJ. Cancer diagnostic profile in children with structural birth defects: An assessment in 15,000 childhood cancer cases.Cancer. 2020 May 29. doi: 10.1002/cncr.32982. Epub ahead of print. PMID: 32469081.

    • Rahman M, Sawyer WG, Lindhorst S, Deleyrolle LP, Harrison JK, Karachi A, Dastmalchi F, Flores-Toro J, Mitchell DA, Lim M, Gilbert MR, Reardon DA. Adult Immuno-Oncology: Using Past Failures to Inform the Future. Neuro Oncol. 2020 May 11:noaa116. doi: 10.1093/neuonc/noaa116. Epub ahead of print. PMID: 32391559.

    • Xu Y, Scharfstein D, Müller P, Daniels M. A Bayesian nonparametric approach for evaluating the causal effect of treatment in randomized trials with semi- competing risks. Biostatistics. 2020 Apr 4:kxaa008. doi:10.1093/biostatistics/kxaa008. Epub ahead of print. PMID: 32247284.

    • ) Hill-Kayser CE, Indelicato DJ, Ermoian R, Salerno K, Breneman J. Pediatric Central Nervous System Germinoma: What Can We Understand From a Worldwide Effort to Maximize Cure and Minimize Risk? Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):227-231. doi: 10.1016/j.ijrobp.2020.03.039. Epub 2020 Apr 7. PMID: 32275995.
  • July – September 

    • Ghiaseddin AP, Shin D, Melnick K, Tran DD. Tumor Treating Fields in the Management of Patients with Malignant Gliomas. Curr Treat Options Oncol. 2020 Jul 30;21(9):76. doi: 10.1007/s11864-020-00773-5. PMID: 32734509; PMCID: PMC7391234.

    • Grippin AJ, Dyson KA, Qdaisat S, McGuiness J, Wummer B, Mitchell DA, Mendez-Gomez HR, Sayour EJ. Nanoparticles as immunomodulators and translational agents in brain tumors. J Neurooncol. 2020 Aug 5. doi: 10.1007/s11060-020-03559-9. Epub ahead of print. PMID: 32757093.

    • Klawinski D, Indelicato DJ, Hossain J, Sandler E. Surveillance imaging in pediatric ependymoma. Pediatr Blood Cancer. 2020 Aug 3:e28622. doi: 10.1002/pbc.28622. Epub ahead of print. PMID: 32743915.

    • Al-Awadhi FH, Salvador-Reyes LA, Elsadek LA, Ratnayake R, Chen QY, Luesch H. Largazole is a Brain-Penetrant Class I HDAC Inhibitor with Extended Applicability to Glioblastoma and CNS Diseases. ACS Chem Neurosci. 2020 Jul 1;11(13):1937-1943. doi: 10.1021/acschemneuro.0c00093. Epub 2020 Jun 19. PMID: 32559056; PMCID: PMC7390227.

    • Rahman M, Sawyer WG, Lindhorst S, Deleyrolle LP, Harrison JK, Karachi A, Dastmalchi F, Flores-Toro J, Mitchell DA, Lim M, Gilbert MR, Reardon DA. Adult immuno-oncology: using past failures to inform the future. Neuro Oncol. 2020 Sep 29;22(9):1249-1261. doi: 10.1093/neuonc/noaa116. PMID: 32391559.

    • Uh J, Merchant TE, Conklin HM, Ismael Y, Li Y, Han Y, Sabin ND, Babajani-Feremi A, Indelicato DJ, Hua CH. Diffusion tensor imaging-based analysis of baseline neurocognitive function and post-treatment white matter changes in pediatric patients with craniopharyngioma treated with surgery and proton therapy. Int J Radiat Oncol Biol Phys. 2020 Sep 5:S0360-3016(20)34219-X. doi:10.1016/j.ijrobp.2020.08.060. Epub ahead of print. PMID: 32898610.

    • Haider SA, Asmaro K, Kalkanis SN, Lee IY, Bazydlo M, Nerenz DR, Salloum RG, Snyder J, Walbert T. The economic impact of glioma survivorship: The cost of care from a patient perspective. Neurology. 2020 Sep 15;95(11):e1575-e1581. doi: 10.1212/WNL.0000000000010263. Epub 2020 Jul 9. PMID: 32646959.

    • Batich KA, Mitchell DA, Healy P, Herndon JE 2nd, Sampson JH. Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma. Clin Cancer Res. 2020 Jul 27. doi: 10.1158/1078-0432.CCR-20-1082. Epub ahead of print. PMID: 32719000.

    • Shin DH, Melnick KF, Tran DD, Ghiaseddin AP. In situ vaccination with laser interstitial thermal therapy augments immunotherapy in malignant gliomas. J Neurooncol. 2020 Aug 5. doi: 10.1007/s11060-020-03557-x. Epub ahead of print. PMID: 32757094.

    • Bates JE, Indelicato DJ, Morris CG, Rotondo RL, Bradley JA. Visual decline in pediatric survivors of brain tumors following radiotherapy. Acta Oncol. 2020 Aug 7:1-6. doi: 10.1080/0284186X.2020.1803500. Epub ahead of print. PMID: 32762400.

    • Radiation therapy combined with intracerebral convection-enhanced delivery of Elleaume H, Barth RF, Rousseau J, Bobyk L, Balosso J, Yang W, Huo T, Nakkulacisplatin or carboplatin for treatment of the F98 rat glioma. J Neurooncol. 2020 Aug 18. doi: 10.1007/s11060-020-03600-x. Epub ahead of print. PMID: 32809095.

    • Wildes TJ, Dyson KA, Francis CP, Wummer BM, Yang C, Yegorov O, Shin D, Grippin AJ, DiVita-Dean B, Abraham RS, Pham CD, Moore G, Kuizon C, Mitchell DA, Flores CT. Immune escape after adoptive T cell therapy for malignant gliomas. Clin Cancer Res. 2020 Aug 11:clincanres.1065.2020. doi: 10.1158/1078-0432.CCR-20-1065. Epub ahead of print. PMID: 32788225.

    • Gandhi GY, Fung R, Natter PE, Makary R, Balaji KC. Symptomatic Pituitary Metastasis as Initial Manifestation of Renal Cell Carcinoma: Case Report and Review of Literature. Case Rep Endocrinol. 2020 Aug 18;2020:8883864. doi: 10.1155/2020/8883864. PMID: 32908722; PMCID: PMC7450332.

    • Schraw JM, Desrosiers TA, Nembhard WN, Langlois PH, Meyer RE, Canfield MA, Rasmussen SA, Chambers TM, Spector LG, Plon SE, Lupo PJ. Cancer diagnostic profile in children with structural birth defects: An assessment in 15,000 childhood cancer cases. Cancer. 2020 Aug 1;126(15):3483-3492. doi: 10.1002/cncr.32982. Epub 2020 May 29. PMID: 32469081.

    • Feria AL, Akinduro OO, Rahmathulla G, Tavanaiepour D. False Localizing Trigeminal V2 Sensory Loss in Vestibular Schwannoma. Cureus. 2020 Jul 18;12(7):e9256. doi: 10.7759/cureus.9256. PMID: 32821602; PMCID: PMC7431979.

University of Miami
  • January – March 
    • Shah AH, Mahavadi AK, Morell A, Eichberg DG, Luther E, Sarkiss CA, Semonche A, Ivan ME, Komotar RJ. Salvage craniotomy for treatment-refractory symptomatic cerebral radiation necrosis. Neurooncol Pract. 2020 Jan;7(1):94-102. doi:10.1093/nop/npz028. Epub 2019 Jul 3. PubMed PMID: 32257288; PubMed Central PMCID:PMC7104877.
    • ) Lu VM, Shah AH, Eichberg DG, Quinones-Hinojosa A, Esquenazi Y, Komotar RJ, Ivan ME. Geographic disparities in access to glioblastoma treatment based on Hispanic ethnicity in the United States: Insights from a national database. JNeurooncol. 2020 Mar 31. doi: 10.1007/s11060-020-03480-1. [Epub ahead of print]PubMed PMID: 32236779.
    • Liyanage PY, Zhou Y, Al-Youbi AO, Bashammakh AS, El-Shahawi MS, Vanni S, Graham RM, Leblanc RM. Pediatric glioblastoma target-specific efficient delivery of gemcitabine across the blood-brain barrier via carbon nitride dots. Nanoscale.2020 Apr 14;12(14):7927-7938. doi: 10.1039/d0nr01647k. Epub 2020 Mar 31. PubMedPMID: 32232249

    • Eichberg DG, Di L, Morell AA, Shah AH, Semonche AM, Chin CN, Bhatia RG, Jamshidi AM, Luther EM, Komotar RJ, Ivan ME. Incidence of high grade gliomas presenting as radiographically non-enhancing lesions: experience in 111 surgically treated non-enhancing gliomas with tissue diagnosis. J Neurooncol.2020 Mar 27. doi: 10.1007/s11060-020-03474-z. [Epub ahead of print] PubMed PMID: 32221785.

    • Perez-Roman RJ, Hubbard ZS, Brusko GD, Starke RM. A case of primary central nervous system lymphoma presenting as a shunt complication. Br J Neurosurg. 2020 Mar 12:1-4. doi: 10.1080/02688697.2020.1735300. [Epub ahead of print] PubMedPMID: 32164443.

    • Dinh CT, Nisenbaum E, Chyou D, Misztal C, Yan D, Mittal R, Young J, Tekin M, Telischi F, Fernandez-Valle C, Liu XZ. Genomics, Epigenetics, and Hearing Loss in Neurofibromatosis Type 2. Otol Neurotol. 2020 Mar 6. doi:10.1097/MAO.0000000000002613. [Epub ahead of print] PubMed PMID: 32150022.

    • Vallejo FA, Shah SS, de Cordoba N, Walters WM, Prince J, Khatib Z, Komotar RJ, Vanni S, Graham RM. The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma. J Neurooncol. 2020Apr;147(2):317-326. doi: 10.1007/s11060-020-03431-w. Epub 2020 Feb 24. PubMedPMID: 32096068.

    • Del Toro E, Risbud A, Khosravani N, Vengerovich G, Archilla A. Sphenoid Wing Meningioma Presenting as Sudden Sensorineural Hearing Loss: A Case Report and Literature Review. Ear Nose Throat J. 2020 Feb 13:145561320905731. doi:10.1177/0145561320905731. [Epub ahead of print] PubMed PMID: 32050788.
    • Subbiah V, Puzanov I, Blay JY, Chau I, Lockhart AC, Raje NS, Wolf J, Baselga J, Meric-Bernstam F, Roszik J, Diamond EL, Riely GJ, Sherman EJ, Riehl T, Pitcher B, Hyman DM. Pan-Cancer Efficacy of Vemurafenib in BRAF (V600)-Mutant Non-Melanoma Cancers. Cancer Discov. 2020 Feb 6. doi:10.1158/2159-8290.CD-19-1265. [Epub ahead of print] PubMed PMID: 32029534.
    • Dominietto M, Pica A, Safai S, Lomax AJ, Weber DC, Capobianco E. Role of Complex Networks for Integrating Medical Images and Radiomic Features of Intracranial Ependymoma Patients in Response to Proton Radiotherapy. Front Med(Lausanne). 2020 Jan 17;6:333. doi: 10.3389/fmed.2019.00333. eCollection 2019.PubMed PMID: 32010703; PubMed Central PMCID: PMC6978687.
    • Spina R, Voss DM, Yang X, Sohn JW, Vinkler R, Schraner J, Sloan A, Welford SM, Avril N, Ames HM, Woodworth GF, Bar EE. MCT4 regulates de novo pyrimidine biosynthesis in GBM in a lactate-independent manner. Neurooncol Adv. 2020Jan-Dec;2(1):vdz062. doi: 10.1093/noajnl/vdz062. Epub 2020 Jan 1. PubMed PMID:32002519; PubMed Central PMCID: PMC6979491.
    • Luther E, McCarthy D, Shah A, Semonche A, Borowy V, Burks J, Eichberg DG, Komotar R, Ivan M. Radical Laser Interstitial Thermal Therapy Ablation Volumes Increase Progression-Free Survival in Biopsy-Proven Radiation Necrosis. World Neurosurg. 2020 Apr;136:e646-e659. doi: 10.1016/j.wneu.2020.01.116. Epub 2020 Jan27. PubMed PMID: 32001408.
    • Mahavadi AK, Patel PM, Kuchakulla M, Shah AH, Eichberg D, Luther EM, Komotar RJ, Ivan ME. Central Neurocytoma Treatment Modalities: A Systematic Review Assessing the Outcomes of Combined Maximal Safe Resection and Radiotherapy with Gross Total Resection. World Neurosurg. 2020 Jan 27. pii: S1878-8750(20)30132-7. doi: 10.1016/j.wneu.2020.01.114. [Epub ahead of print] PubMed PMID: 32001392.
    • Silva MA, See AP, Sur S, Aziz-Sultan MA. Treatment of complex intracranial pathologies with transcirculation endovascular approaches. Neurocirugia (Astur). 2020 Jan 24. pii: S1130-1473(19)30120-4. doi: 10.1016/j.neucir.2019.10.003. [Epub ahead of print] English, Spanish. PubMed PMID: 31987753.
    • Chen X, Lin L, Wu J, Yang G, Zhong T, Du X, Chen Z, Xu G, Song Y, Xue Y, Duan Q. Histogram analysis in predicting the grade and histological subtype of meningiomas based on diffusion kurtosis imaging. Acta Radiol. 2020 Jan27:284185119898656. doi: 10.1177/0284185119898656. [Epub ahead of print] PubMedPMID: 31986895.
    • Figueroa J, Morell A, Bowory V, Shah AH, Eichberg D, Buttrick SS, Richardson A, Sarkiss C, Ivan ME, Komotar RJ. Minimally invasive keyhole temporal lobectomy approach for supramaximal glioma resection: A safety and feasibility study. JClin Neurosci. 2020 Feb;72:57-62. doi: 10.1016/j.jocn.2020.01.031. Epub 2020 Jan 14. PubMed PMID: 31948883.
    • Luther EM, McCarthy D, Berry KM, Rajulapati N, Shah AH, Eichberg DG, Komotar RJ, Ivan M. Hospital teaching status associated with reduced inpatient mortality and perioperative complications in surgical neuro-oncology. J Neurooncol. 2020Jan;146(2):389-396. doi: 10.1007/s11060-020-03395-x. Epub 2020 Jan 14. PubMedPMID: 31939029.
    • Lee DJ, Koru-Sengul T, Hernandez MN, Caban-Martinez AJ, McClure LA, Mackinnon JA, Kobetz EN. Cancer risk among career male and female Florida firefighters: Evidence from the Florida Firefighter Cancer Registry (1981-2014). Am J Ind Med. 2020 Apr;63(4):285-299. doi: 10.1002/ajim.23086. Epub 2020 Jan 12. PubMed PMID:31930542
    • Figueroa JM, Semonche A, Magoon S, Shah A, Luther E, Eichberg D, Komotar R, Ivan ME. The role of neutrophil-to-lymphocyte ratio in predicting overall survival in patients undergoing laser interstitial thermal therapy for glioblastoma. J Clin Neurosci. 2020 Feb;72:108-113. doi: 10.1016/j.jocn.2019.12.057. Epub 2020 Jan 7. PubMed PMID: 31918907.
    • Hollon TC, Pandian B, Adapa AR, Urias E, Save AV, Khalsa SSS, Eichberg DG, D’Amico RS, Farooq ZU, Lewis S, Petridis PD, Marie T, Shah AH, Garton HJL, Maher CO, Heth JA, McKean EL, Sullivan SE, Hervey-Jumper SL, Patil PG, Thompson BG, Sagher O, McKhann GM 2nd, Komotar RJ, Ivan ME, Snuderl M, Otten ML, Johnson TD, Sisti MB, Bruce JN, Muraszko KM, Trautman J, Freudiger CW, Canoll P, Lee H, Camelo-Piragua S, Orringer DA. Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networks. Nat Med. 2020 Jan;26(1):52-58. doi: 10.1038/s41591-019-0715-9. Epub 2020 Jan 6. PubMed PMID: 31907460; PubMed Central PMCID: PMC6960329.
    • Colaprico A, Olsen C, Bailey MH, Odom GJ, Terkelsen T, Silva TC, Olsen AV, Cantini L, Zinovyev A, Barillot E, Noushmehr H, Bertoli G, Castiglioni I, Cava C, Bontempi G, Chen XS, Papaleo E. Interpreting pathways to discover cancer driver genes with Moonlight.Nat Commun. 2020 Jan 3;11(1):69. doi: 10.1038/s41467-019-13803-0. PubMed PMID: 31900418; PubMed Central PMCID: PMC6941958.
    • Richardson AM. In Reply to the Letter to the Editor Regarding “Central Neurocytoma: Rare Presentation in Fourth Ventricle and Review of Literature”. World Neurosurg. 2020 Jan;133:445. doi: 10.1016/j.wneu.2019.10.031. PubMed PMID: 31881568.
    • Goryawala M, Saraf-Lavi E, Nagornaya N, Heros D, Komotar R, Maudsley AA. The Association between Whole-Brain MR Spectroscopy and IDH Mutation Status in Gliomas. J Neuroimaging. 2020 Jan;30(1):58-64. doi: 10.1111/jon.12685. Epub 2019 Dec 23. PubMed PMID: 31868291.
    •  Epstein RH, Dexter F, Cajigas I, Mahavadi AK, Shah AH, Abitbol N, Komotar RJ. Prolonged tracheal extubation time after glioma surgery was associated with lack of familiarity between the anesthesia provider and the operating neurosurgeon. A retrospective, observational study. J Clin Anesth. 2020 Mar;60:118-124. doi: 10.1016/j.jclinane.2019.09.003. Epub 2019 Oct 24. PubMed PMID: 31669746.
    •  Ripa V, Kwon CS, Burks JD, Morcos JJ. Neuro-Behcet Disease Mimicking Lymphoma of the Brain and Coexisting with A Dural Arteriovenous Fistula: A Case Report. World Neurosurg. 2020 Jan;133:205-211. doi: 10.1016/j.wneu.2019.09.035. Epub 2019 Sep 13. PubMed PMID: 31525480.
    • Wang J, Foley M, Kuker R. Pituitary Adenoma on 18F-Fluciclovine PET/CT. Clin Nucl Med. 2020 Jan;45(1):e65-e66. doi: 10.1097/RLU.0000000000002777. PubMed PMID: 31524674.
    • Mahavadi AK, Shah AH, Komotar RJ. Commentary: Optimizing Postoperative Surveillance of Pediatric Low-Grade Glioma Using Tumor Behavior Patterns. Neurosurgery. 2020 Feb 1;86(2):E137-E139. doi: 10.1093/neuros/nyz124. PubMed PMID: 31329955.
    • Zenonos GA, Morcos JJ. Occipital to Angular Artery Bypass for Post-irradiation Ischemia: 3-Dimensional Operative Video. Oper Neurosurg (Hagerstown). 2020 Mar 1;18(3):E78. doi: 10.1093/ons/opz125. PubMed PMID: 31173139.
  • April – June
    • Subbiah V, Puzanov I, Blay JY, Chau I, Lockhart AC, Raje NS, Wolf J, Baselga J, Meric-Bernstam F, Roszik J, Diamond EL, Riely GJ, Sherman EJ, Riehl T, Pitcher B, Hyman DM. Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers. Cancer Discov. 2020 May;10(5):657-663. doi: 10.1158/2159-8290.CD-19-1265. Epub 2020 Feb 6. PMID: 32029534; PMCID: PMC7196502.
    • Mahavadi AK, Patel PM, Kuchakulla M, Shah AH, Eichberg D, Luther EM, Komotar RJ, Ivan ME. Central Neurocytoma Treatment Modalities: A Systematic Review Assessing the Outcomes of Combined Maximal Safe Resection and Radiotherapy with Gross Total Resection. World Neurosurg. 2020 May;137:e176-e182. doi: 10.1016/j.wneu.2020.01.114. Epub 2020 Jan 27. PMID: 32001392.

    • Lee DJ, Koru-Sengul T, Hernandez MN, Caban-Martinez AJ, McClure LA, Mackinnon JA, Kobetz EN. Cancer risk among career male and female Florida firefighters: Evidence from the Florida Firefighter Cancer Registry (1981-2014). Am J Ind Med. 2020 Apr;63(4):285-299. doi: 10.1002/ajim.23086. Epub 2020 Jan 12. PMID: 31930542.

    • Vallejo FA, Shah SS, de Cordoba N, Walters WM, Prince J, Khatib Z, Komotar RJ, Vanni S, Graham RM. The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma. J Neurooncol. 2020 Apr;147(2):317-326. doi: 10.1007/s11060-020-03431-w. Epub 2020 Feb 24. PMID: 32096068.
    • Lu VM, O’Connor KP, Shah AH, Eichberg DG, Luther EM, Komotar RJ, Ivan ME. The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature. J Neurooncol. 2020 Jun;148(2):221-229. doi: 10.1007/s11060-020-03528-2. Epub 2020 May 8. PMID: 32385699.
    • Liyanage PY , Zhou Y , Al-Youbi AO , Bashammakh AS , El-Shahawi MS , Vanni S, Graham  RM , Leblanc RM . Pediatric glioblastoma target-specific efficient delivery of gemcitabine across the blood-brain barrier via carbon nitride dots. Nanoscale. 2020 Apr 14;12(14):7927-7938. doi: 10.1039/d0nr01647k. Epub 2020 Mar 31. PMID: 32232249.
    • Mahavadi AK, Temmins C, Patel MR, Singh H. Supratentorial intraventricular rosette-forming glioneuronal tumors – Case report and review of treatment paradigms. Surg Neurol Int. 2020 Jun 6;11:138. doi: 10.25259/SNI_188_2019. PMID: 32547825; PMCID: PMC7294172.
    • Eichberg DG, Di L, Morell AA, Shah AH, Semonche AM, Chin CN, Bhatia RG, Jamshidi AM, Luther EM, Komotar RJ, Ivan ME. Incidence of high grade gliomas presenting as radiographically non-enhancing lesions: experience in 111 surgically treated non-enhancing gliomas with tissue diagnosis. J Neurooncol. 2020 May;147(3):671-679. doi: 10.1007/s11060-020-03474-z. Epub 2020 Mar 27. PMID: 32221785.

    • Mellinghoff IK, Ellingson BM, Touat M, Maher E, De La Fuente MI, Holdhoff M, Cote GM, Burris H, Janku F, Young RJ, Huang R, Jiang L, Choe S, Fan B, Yen K, Lu M, Bowden C, Steelman L, Pandya SS, Cloughesy TF, Wen PY. Ivosidenib in  Isocitrate Dehydrogenase 1-Mutated Advanced Glioma. J Clin Oncol. 2020 Jun 12:JCO1903327. doi: 10.1200/JCO.19.03327. Epub ahead of print. PMID: 32530764.

    • Di L, Heath RN, Shah AH, Sanjurjo AD, Eichberg DG, Luther EM, de la Fuente MI, Komotar RJ, Ivan ME. Resection versus biopsy in the treatment of multifocal glioblastoma: a weighted survival analysis. J Neurooncol. 2020 May;148(1):155-164. doi: 10.1007/s11060-020-03508-6. Epub 2020 May 11. PMID: 32394325.

    • Ramesh K, Gurbani SS, Mellon EA, Huang V, Goryawala M, Barker PB, Kleinberg L, Shu HG, Shim H, Weinberg BD. The Longitudinal Imaging Tracker (BrICS-LIT): A Cloud Platform for Monitoring Treatment Response in Glioblastoma Patients.Tomography. 2020 Jun;6(2):93-100. doi: 10.18383/j.tom.2020.00001. PMID: 32548285; PMCID: PMC7289246.

    • Dinh CT, Nisenbaum E, Chyou D, Misztal C, Yan D, Mittal R, Young J, Tekin M, Telischi F, Fernandez-Valle C, Liu XZ. Genomics, Epigenetics, and Hearing Loss in Neurofibromatosis Type 2. Otol Neurotol. 2020 Jun;41(5):e529-e537. doi:10.1097/MAO.0000000000002613. PMID: 32150022.
    • Daggubati LC, Eichberg DG, Ivan ME, Hanft S, Mansouri A, Komotar RJ, D’Amico RS, Zacharia BE. Telemedicine for Outpatient Neurosurgical Oncology Care: Lessons Learned for the Future During the COVID-19 Pandemic. World Neurosurg. 2020 May 22:S1878-8750(20)31111-6. doi: 10.1016/j.wneu.2020.05.140. Epub ahead of print. PMID: 32450309; PMCID: PMC7243783.
    • Eichberg DG, Di L, Shah AH, Luther EM, Jackson C, Marenco-Hillembrand L, Chaichana KL, Ivan ME, Starke RM, Komotar RJ. Minimally invasive resection of intracranial lesions using tubular retractors: a large, multi-surgeon, multi-institutional series. J Neurooncol. 2020 Jun 18. doi:10.1007/s11060-020-03500-0. Epub ahead of print. PMID: 32556805.
    • Lu VM, Shah AH, Eichberg DG, Quinones-Hinojosa A, Esquenazi Y, Komotar RJ, Ivan ME. Geographic disparities in access to glioblastoma treatment based on Hispanic ethnicity in the United States: Insights from a national database. J Neurooncol. 2020 May;147(3):711-720. doi: 10.1007/s11060-020-03480-1. Epub 2020 Mar 31. PMID: 32236779.
    • Luther E, McCarthy D, Shah A, Semonche A, Borowy V, Burks J, Eichberg DG, Komotar R, Ivan M. Radical Laser Interstitial Thermal Therapy Ablation Volumes Increase Progression-Free Survival in Biopsy-Proven Radiation Necrosis. World Neurosurg. 2020 Apr;136:e646-e659. doi: 10.1016/j.wneu.2020.01.116. Epub 2020 Jan 27. PMID: 32001408.
    • Shah AH, Mahvadi AK, Ivan ME, Komotar RJ. Commentary: Gross Total Resection of a Grade IV Astrocytoma Adjacent to the Precentral Gyrus With Nonawake Motor Mapping and Motor-Evoked Potential Monitoring: 3-Dimensional Operative Video. Oper Neurosurg (Hagerstown). 2020 Apr 1;18(4):E129-E130. doi: 10.1093/ons/opz212. PMID: 31919526.
    • Zacharia BE, Eichberg DG, Ivan ME, Hanft S, Boockvar JA, Isildak H, Mansouri A, Komotar RJ, D’Amico RS. Letter: Surgical Management of Brain Tumor Patients in the COVID-19 Era. Neurosurgery. 2020 Apr 29:nyaa162. doi: 10.1093/neuros/nyaa162. Epub ahead of print. PMID: 32347942; PMCID: PMC7197540.
    • Russell JF, Shi Y, Gregori G, Rosenfeld PJ. Longitudinal Swept-Source OCT Angiography of Juxtapapillary Retinal Capillary Hemangioblastoma. Ophthalmol Retina. 2020 May 8:S2468-6530(20)30194-9. doi: 10.1016/j.oret.2020.05.002. Epub ahead of print. PMID: 32438081.
    • Lu VM, Power EA, Zhang L, Daniels DJ. Overcoming the Blood-Brain Barrier to Target Diffuse Intrinsic Pontine Glioma: What’s New? World Neurosurg. 2020 May 7:S1878-8750(20)30968-2. doi: 10.1016/j.wneu.2020.05.008. Epub ahead of print. PMID: 32389870.
  • July – September

    • Suter RK, Rodriguez-Blanco J, Ayad NG. Epigenetic pathways and plasticity in brain tumors. Neurobiol Dis. 2020 Aug 30;145:105060. doi:10.1016/j.nbd.2020.105060. Epub ahead of print. PMID: 32877743.

    • Elarjani T, Altewerki M, Alsuwaidan A, Alhuthayl M, Hassounah M. Molecular Association of Medulloblastoma and Sarcoidosis: Case Report and Review of the Literature. World Neurosurg. 2020 Sep 30:S1878-8750(20)32154-9. doi: 10.1016/j.wneu.2020.09.135. Epub ahead of print. PMID: 33010513.

    • Vadhan JD, Eichberg DG, Di L, Manzano G, Ivan M, Komotar RJ. Primary Low- Grade Astrocytoma of the Spine With Secondary Cerebral Metastasis: A Case Report and Comprehensive Review of the Literature. Cureus. 2020 Aug 25;12(8):e10030. doi: 10.7759/cureus.10030. PMID: 32983723; PMCID: PMC7515806.

    • Eichberg DG, Menaker SA, Jermakowicz WJ, Shah AH, Luther EM, Jamshidi AM, Semonche AM, Di L, Komotar RJ, Ivan ME. Multiple Iterations of Magnetic Resonance-Guided Laser Interstitial Thermal Ablation of Brain Metastases: Single Surgeon’s Experience and Review of the Literature. Oper Neurosurg (Hagerstown). 2020 Aug 1;19(2):195-204. doi: 10.1093/ons/opz375. PMID: 31828344.

    • Daggubati LC, Eichberg DG, Ivan ME, Hanft S, Mansouri A, Komotar RJ, D’Amico RS, Zacharia BE. Telemedicine for Outpatient Neurosurgical Oncology Care: Lessons Learned for the Future During the COVID-19 Pandemic. World Neurosurg. 2020 Jul;139:e859-e863. doi: 10.1016/j.wneu.2020.05.140. Epub 2020 May 22. PMID: 32450309; PMCID: PMC7243783.

    • Shah AH, Semonche A, Eichberg DG, Borowy V, Luther E, Sarkiss CA, Morell A, Mahavadi AK, Ivan ME, Komotar RJ. The Role of Laser Interstitial Thermal Therapy in Surgical Neuro-Oncology: Series of 100 Consecutive Patients. Neurosurgery. 2020 Aug 1;87(2):266-275. doi: 10.1093/neuros/nyz424. PMID: 31742351.

    • Luther E, Mansour S, Echeverry N, McCarthy D, Eichberg DG, Shah A, Nada A, Berry K, Kader M, Ivan M, Komotar R. Laser Ablation for Cerebral Metastases. Neurosurg Clin N Am. 2020 Oct;31(4):537-547. doi: 10.1016/j.nec.2020.06.004. Epub 2020 Aug 10. PMID: 32921350.

    • Siada RG, Lu VM, Daniels DJ. Understanding the trajectory of research efforts in atypical teratoid rhabdoid tumors: a bibliometric analysis of the 50 most impactful studies to date. Childs Nerv Syst. 2020 Aug 17. doi: 10.1007/s00381-020-04863-5. Epub ahead of print. PMID: 32808066

    • Mansour S, Luther E, Echeverry N, McCarthy D, Eichberg DG, Shah A, Matus A, Chen S, Gultekin SH, Ivan M, Morcos J. Rare Tumor-to-Tumor Metastases Involving Lung Adenocarcinoma to Petroclival Meningiomas. World Neurosurg. 2020 Jul 27;144:125-135. doi: 10.1016/j.wneu.2020.07.140. Epub ahead of print. PMID: 32730974.

    • Lu VM, O’Connor KP, Himes BT, Brown DA, Nesvick CL, Siada RG, Niazi TN, Schwartz J, Daniels DJ. Effect of surgery and chemotherapy on long-term survival in infants with congenital glioblastoma: an integrated survival analysis. J Neurosurg Pediatr. 2020 Aug 14:1-9. doi: 10.3171/2020.5.PEDS20226. Epub ahead of print. PMID: 32796143.

    • Jamshidi AM, Eichberg DG, Komotar RJ, Ivan M. Safety Analysis of Bilateral Laser Interstitial Thermal Therapy for Treatment of Butterfly Glioma. World Neurosurg. 2020 Aug 11:S1878-8750(20)31820-9. doi: 10.1016/j.wneu.2020.08.053. Epub ahead of print. PMID: 32795682.

    • Tan SK, Luther E, Eichberg D, Shah A, Khan K, Jamshidi A, Ivan M, Gultekin SH, Komotar R. Complete Regression of a Solitary Cholangiocarcinoma Brain Metastasis Following Laser Interstitial Thermal Therapy. World Neurosurg. 2020 Aug 22;144:94-98. doi: 10.1016/j.wneu.2020.08.122. Epub ahead of print. PMID: 32841795.

    • Benjamin C, Ashayeri K, Golfinos JG, Placantonakis DG, Silverman J, Kondziolka D. Treatment of sellar metastases with gamma knife radiosurgery in patients with advanced cancer. Pituitary. 2020 Aug 29. doi: 10.1007/s11102-020-01074-8. Epub ahead of print. PMID: 32860552.

    • Zhou W, Liu X, van Wijnbergen JWM, Yuan L, Liu Y, Zhang C, Jia W. Identification of PIEZO1 as a potential prognostic marker in gliomas. Sci Rep. 2020 Sep 30;10(1):16121. doi: 10.1038/s41598-020-72886-8. PMID: 32999349; PMCID: PMC7528027.

    • Zheng S, Tao W. Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme. Cancers (Basel). 2020 Aug 21;12(9):E2368. doi: 10.3390/cancers12092368. PMID: 32825640.

    • Silva MA, See AP, Sur S, Aziz-Sultan MA. Treatment of complex intracranial pathologies with transcirculation endovascular approaches. Neurocirugia (Astur). 2020 Jul-Aug;31(4):173-183. English, Spanish. doi: 10.1016/j.neucir.2019.10.003. Epub 2020 Jan 24. PMID: 31987753.

    • Lu VM, Power EA, Zhang L, Daniels DJ. Overcoming the Blood-Brain Barrier to Target Diffuse Intrinsic Pontine Glioma: What’s New? World Neurosurg. 2020 Jul;139:618-619. doi: 10.1016/j.wneu.2020.05.008. Epub 2020 May 7. PMID: 32389870.

    • Lu VM, Shah AH, Eichberg DG, Luther EM, Shah SS, Komotar RJ, Ivan ME. Utilizing systematic reviews and meta-analyses effectively to evaluate brain tumor biomarkers. Biomark Med. 2020 Jul;14(10):817-820. doi: 10.2217/bmm-2020-0209. Epub 2020 Aug 17. PMID: 32799644.

    •  Siada RG, Lu VM, Schwartz J, Daniels DJ. Recurring pediatric anaplastic ependymoma with rare peritoneal carcinomatosis: a case report and hypothesis of mechanism. Childs Nerv Syst. 2020 Jul 17. doi: 10.1007/s00381-020-04814-0. Epub ahead of print. PMID: 32681369.

    • Chen X, Lin L, Wu J, Yang G, Zhong T, Du X, Chen Z, Xu G, Song Y, Xue Y, Duan Q. Histogram analysis in predicting the grade and histological subtype of meningiomas based on diffusion kurtosis imaging. Acta Radiol. 2020 Sep;61(9):1228-1239. doi: 10.1177/0284185119898656. Epub 2020 Jan 27. PMID: 31986895.

    • Eichberg DG, Komotar RJ, Ivan ME. Commentary: Endoscopic Endonasal Approach for Resection of Suprasellar Hemangioblastoma: Selective Pituitary Sacrifice and Use of Indocyanine Dye: 2-Dimensional Operative Video. Oper Neurosurg (Hagerstown). 2020 Aug 19:opaa258. doi: 10.1093/ons/opaa258. Epub ahead of print. PMID: 32814977.

    • Eichberg DG, Di L, Shah AH, Luther EM, Jackson C, Marenco-Hillembrand L, Chaichana KL, Ivan ME, Starke RM, Komotar RJ. Minimally invasive resection of intracranial lesions using tubular retractors: a large, multi-surgeon, multi- institutional series. J Neurooncol. 2020 Aug;149(1):35-44. doi: 10.1007/s11060-020-03500-0. Epub 2020 Jun 18. PMID: 32556805.

    • Shah AH, Mahavadi A, Di L, Sanjurjo A, Eichberg DG, Borowy V, Figueroa J, Luther E, de la Fuente MI, Semonche A, Ivan ME, Komotar RJ. Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection. J Neurooncol. 2020 Jul;148(3):501-508. doi: 10.1007/s11060-020-03541-5. Epub 2020 Jul 5. PMID: 32627128; PMCID: PMC7442660.

    • Zacharia BE, Eichberg DG, Ivan ME, Hanft S, Boockvar JA, Isildak H, Mansouri A, Komotar RJ, D’Amico RS. Letter: Surgical Management of Brain Tumor Patients in the COVID-19 Era. Neurosurgery. 2020 Aug 1;87(2):E197-E200. doi: 10.1093/neuros/nyaa162. PMID: 32347942; PMCID: PMC7197540.

    • Tejera D, Kushnirsky M, Gultekin SH, Lu M, Steelman L, de la Fuente MI. Ivosidenib, an IDH1 inhibitor, in a patient with recurrent, <i>IDH1</i>-mutant glioblastoma: a case report from a Phase I study. CNS Oncol. 2020 Jul 27:CNS62. doi: 10.2217/cns-2020-0014. Epub ahead of print. PMID: 32716208.

    • Sprau A, Mahavadi A, Zhang M, Saste M, Deftos M, Singh H. Rathke’s cleft cyst with xanthogranulomatous change: A case report and review of the literature. Surg Neurol Int. 2020 Aug 15;11:246. doi: 10.25259/SNI_277_2020. PMID: 32905293; PMCID: PMC7468188.

    • Alabiad CR, Shah VS, Eatz TA, Sternau LL, Lam BL. Malignant optic nerve glioma in a young woman with 7 year follow up without recurrence. Am J Ophthalmol Case Rep. 2020 Aug 11;19:100862. doi: 10.1016/j.ajoc.2020.100862. PMID: 32875146; PMCID: PMC7452041.

    • Russell JF, Shi Y, Gregori G, Rosenfeld PJ. Longitudinal Swept-Source OCT Angiography of Juxtapapillary Retinal Capillary Hemangioblastoma. Ophthalmol Retina. 2020 Sep;4(9):956-958. doi: 10.1016/j.oret.2020.05.002. Epub 2020 May 8. PMID: 32438081; PMCID: PMC7484327.

    • Eichberg DG, Komotar RJ, Ivan ME. Commentary: Altered Motor Excitability in Patients With Diffuse Gliomas Involving Motor Eloquent Areas: The Impact of Tumor Grading. Neurosurgery. 2020 Sep 5:nyaa390. doi: 10.1093/neuros/nyaa390. Epub ahead of print. PMID: 32888310.

    • Eichberg DG, Komotar RJ, Ivan ME. Commentary: Microsurgical Transcranial Approach of 112 Paraoptic Meningiomas: A Single-Center Case Series. Oper Neurosurg (Hagerstown). 2020 Jul 25:opaa233. doi: 10.1093/ons/opaa233. Epub ahead of print. PMID: 32710759.

Mayo Clinic, Florida
  • January – March 
    • Sebastian NT, Glenn C, Hughes R, Raval R, Chu J, DiCostanzo D, Bell EH, Grecula J, Arnett A, Gondal H, McGregor J, Elder JB, Lonser R, Chakravarti A, Trifiletti D, Brown PD, Chan M, Palmer JD. Linear accelerator-based radiosurgery is associated with lower incidence of radionecrosis compared with gamma knife for treatment of multiple brain metastases. Radiother Oncol. 2020 Mar 30;147:136-143. doi: 10.1016/j.radonc.2020.03.024. [Epub ahead of print] PubMed PMID: 32294607.
    • Lu VM, Shah AH, Eichberg DG, Quinones-Hinojosa A, Esquenazi Y, Komotar RJ, Ivan ME. Geographic disparities in access to glioblastoma treatment based on Hispanic ethnicity in the United States: Insights from a national database. J Neurooncol. 2020 Mar 31. doi: 10.1007/s11060-020-03480-1. [Epub ahead of print] PubMed PMID: 32236779.
    • von Roemeling CA, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, Yang Z, Yang M, Deng W, Bruno KA, Chan CK, Lee AS, Rosenfeld SS, Yun K, Johnson AJ, Mitchell DA, Jiang W, Kim BYS. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020 Mar 20;11(1):1508. doi: 10.1038/s41467-020-15129-8. PubMed PMID: 32198351; PubMed Central PMCID: PMC7083893.
    • Seneviratne DS, Vallow LA, Hadley A, Malouff TD, Stross WC, Herchko S, Pafundi DH, Trifiletti DM, Peterson JL. Intracranial motion during frameless Gamma-Knife stereotactic radiosurgery. J Radiosurg SBRT. 2020;6(4):277-285. PubMed PMID: 32185087; PubMed Central PMCID: PMC7065895.
    • Stross WC, Malouff TD, Waddle MR, Miller RC, Peterson J, Trifiletti DM. Proton beam therapy utilization in adults with primary brain tumors in the United States. J Clin Neurosci. 2020 Mar 14. pii: S0967-5868(20)30013-8. doi: 10.1016/j.jocn.2020.03.011. [Epub ahead of print] PubMed PMID: 32184042.
    • Marenco-Hillembrand L, Wijesekera O, Suarez-Meade P, Mampre D, Jackson C, Peterson J, Trifiletti D, Hammack J, Ortiz K, Lesser E, Spiegel M, Prevatt C, Hawayek M, Quinones-Hinojosa A, Chaichana KL. Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis. J Neurooncol. 2020 Apr;147(2):297-307. doi: 10.1007/s11060-020-03451-6. Epub 2020 Mar 9. Review. PubMed PMID: 32157552.
    • Tatum WO, McKay JH, ReFaey K, Feyissa AM, Ryan D, Ritaccio A, Middlebrooks E, Yelvington K, Roth G, Acton E, Grewal S, Chaichana K, Quinones-Hinojosa A. Detection of after-discharges during intraoperative functional brain mapping in awake brain tumor surgery using a novel high-density circular grid. Clin Neurophysiol. 2020 Apr;131(4):828-835. doi: 10.1016/j.clinph.2019.12.416. Epub 2020 Jan 30. PubMed PMID: 32066101.
    • Lehrer EJ, McGee HM, Sheehan JP, Trifiletti DM. Integration of
      immuno-oncology with stereotactic radiosurgery in the management of brain
      metastases. J Neurooncol. 2020 Feb 12. doi: 10.1007/s11060-020-03427-6. [Epub ahead of print] Review. PubMed PMID: 32052355.
    • Brown DA, Lu VM, Himes BT, Burns TC, Quiñones-Hinojosa A, Chaichana KL,
      Parney IF. Breast brain metastases are associated with increased risk of
      leptomeningeal disease after stereotactic radiosurgery: a systematic review and
      meta-analysis. Clin Exp Metastasis. 2020 Apr;37(2):341-352. doi:
      10.1007/s10585-020-10019-1. Epub 2020 Jan 16. PubMed PMID: 31950392.
    • Schiapparelli P, Zhang P, Lara-Velazquez M, Guerrero-Cazares H, Lin R, Su H, Chakroun RW, Tusa M, Quiñones-Hinojosa A, Cui H. Self-assembling and self-formulating prodrug hydrogelator extends survival in a glioblastoma resection and recurrence model. J Control Release. 2020 Mar 10;319:311-321. doi: 10.1016/j.jconrel.2020.01.003. Epub 2020 Jan 3. PubMed PMID: 31911154.
    • González-Darder JM, Capilla-Guasch P, Escartín FP, Quilis-Quesada V. Side-to-End Hypoglossal-Facial Neurorrhaphy for Treatment of Complete and Irreversible Facial Paralysis after Vestibular Schwannoma Removal by Means of a Retrosigmoid Approach: A Clinical and Anatomic Study. World Neurosurg. 2020 Apr;136:e262-e269. doi: 10.1016/j.wneu.2019.12.149. Epub 2020 Jan 2. PubMed PMID: 31904436.
    • Materi J, Mampre D, Ehresman J, Rincon-Torroella J, Chaichana KL. Predictors of recurrence and high growth rate of residual meningiomas after subtotal resection. J Neurosurg. 2020 Jan 3:1-7. doi: 10.3171/2019.10.JNS192466. [Epub ahead of print] PubMed PMID: 31899874.
    • Yang Z, Shi J, Xie J, Wang Y, Sun J, Liu T, Zhao Y, Zhao X, Wang X, Ma Y, Malkoc V, Chiang C, Deng W, Chen Y, Fu Y, Kwak KJ, Fan Y, Kang C, Yin C, Rhee J, Bertani P, Otero J, Lu W, Yun K, Lee AS, Jiang W, Teng L, Kim BYS, Lee LJ. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat Biomed Eng. 2020 Jan;4(1):69-83. doi: 10.1038/s41551-019-0485-1. Epub 2019 Dec 16. PubMed PMID: 31844155; PubMed Central PMCID: PMC7080209.
    • Lu VM, Akinduro OO, Daniels DJ. H3K27M mutation in adult cerebellar glioblastoma. J Clin Neurosci. 2020 Jan;71:316-317. doi: 10.1016/j.jocn.2019.11.016. Epub 2019 Dec 13. PubMed PMID: 31843430.
    • Goldstein ED, Kyper CM, Siegel JL. Diffuse Midline Glioma H3 K27M-Mutant Manifested as Progressive Paraplegia.Neurohospitalist. 2020 Jan;10(1):73-74. doi: 10.1177/1941874419847347. Epub 2019 May 7. PubMed PMID: 31839872; PubMed Central PMCID: PMC6900658.
    • Mackintosh C, Tewari A, Siegel J, Wang RD, Freeman W. Postoperative Euglycemic Diabetic Ketoacidosis and Encephalopathy Related to SGLT-2 Inhibitors: A Case Report and Discussion of Diabetes Treatment and “Sweet Pee Encephalopathy” in Perioperative Hospital Management. Neurohospitalist. 2020 Jan;10(1):51-54. doi: 10.1177/1941874419835035. Epub 2019 Mar 7. PubMed PMID: 31839866; PubMed Central PMCID: PMC6900651.
    • Singh R, Lehrer EJ, Ko S, Peterson J, Lou Y, Porter AB, Kotecha R, Brown PD, Zaorsky NG, Trifiletti DM. Brain metastases from non-small cell lung cancer with EGFR or ALK mutations: A systematic review and meta-analysis of multidisciplinary approaches. Radiother Oncol. 2020 Mar;144:165-179. doi: 10.1016/j.radonc.2019.11.010. Epub 2019 Dec 5. Review. PubMed PMID: 31812932.  

    • Tawk RG, Akinduro OO, Grewal SS, Brasiliense L, Grand W, Grotenhuis A. Endoscopic Transforaminal Transchoroidal Approach to the Third Ventricle for Cystic and Solid Tumors. World Neurosurg. 2020 Feb;134:e453-e459. doi: 10.1016/j.wneu.2019.10.099. Epub 2019 Oct 24. PubMed PMID: 31669244.

    • Trifiletti DM, Ballman KV, Brown PD, Anderson SK, Carrero XW, Cerhan JH, Whitton AC, Greenspoon J, Parney IF, Laack NN, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):255-260. doi: 10.1016/j.ijrobp.2019.10.024. Epub 2019 Oct 22. Erratum in: Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):1111. PubMed PMID: 31654784; PubMed Central PMCID: PMC6957747.
  • April – June
    • Damon A, Clifton W, Valero-Moreno F, Quinones-Hinojosa A. Cost-Effective Method for 3-Dimensional Printing Dynamic Multiobject and Patient-Specific Brain Tumor Models: Technical Note. World Neurosurg. 2020 Apr 30;140:173-179. doi:10.1016/j.wneu.2020.04.184. Epub ahead of print. PMID: 32360916.
    • González-Darder JM, Capilla-Guasch P, Escartín FP, Quilis-Quesada V. Side-to- End Hypoglossal-Facial Neurorrhaphy for Treatment of Complete and Irreversible Facial Paralysis after Vestibular Schwannoma Removal by Means of a Retrosigmoid Approach: A Clinical and Anatomic Study. World Neurosurg. 2020 Apr;136:e262-e269. doi: 10.1016/j.wneu.2019.12.149. Epub 2020 Jan 2. PMID: 31904436.
    • Rusthoven CG, Yamamoto M, Bernhardt D, Smith DE, Gao D, Serizawa T, Yomo S, Aiyama H, Higuchi Y, Shuto T, Akabane A, Sato Y, Niranjan A, Faramand AM, Lunsford LD, McInerney J, Tuanquin LC, Zacharia BE, Chiang V, Singh C, Yu JB, Braunstein S, Mathieu D, Touchette CJ, Lee CC, Yang HC, Aizer AA, Cagney DN, Chan MD, Kondziolka D, Bernstein K, Silverman JS, Grills IS, Siddiqui ZA, YuanJC, Sheehan JP, Cordeiro D, Nosaki K, Seto T, Deibert CP, Verma V, Day S, Halasz LM, Warnick RE, Trifiletti DM, Palmer JD, Attia A, Li B, Cifarelli CP, Brown PD, Vargo JA, Combs S, Kessel KA, Rieken S, Patel S, Guckenberger M, Andratschke N, Kavanagh BD, Robin TP. Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study. JAMA Oncol. 2020 Jun 4:e201271. doi: 10.1001/jamaoncol.2020.1271. Epub ahead of print. PMID: 32496550; PMCID: PMC7273318.
    • Peacock SH, Grek AA, Rogers ER, Freeman WD, White LJ, Li Z, Hartjes T, Naessens JM. Neuro R2 score: Predicting high-risk neurologic readmissions within 30 days. Neurology. 2020 Apr 14;94(15):e1614-e1621. doi: 10.1212/WNL.0000000000009252. Epub 2020 Mar 13. PMID: 32170035.
    • Domingo RA, Tripathi S, Vivas-Buitrago T, Lu VM, Chaichana KL, Quiñones- Hinojosa A. Mitotic Index and Progression Free Survival in Atypical Meningiomas. World Neurosurg. 2020 Jun 29:S1878-8750(20)31457-1. doi: 10.1016/j.wneu.2020.06.189. Epub ahead of print. PMID: 32615290.
    • Brown DA, Hanalioglu S, Chaichana K, Duffau H. Transcorticosubcortical Approach for Left Posterior Mediobasal Temporal Region Gliomas: A Case Series and Anatomic Review of Relevant White Matter Tracts. World Neurosurg. 2020 Apr 29:S1878-8750(20)30854-8. doi: 10.1016/j.wneu.2020.04.147. Epub ahead of print. PMID: 32360919.
    • Lopez-Bertoni H, Kotchetkov IS, Mihelson N, Lal B, Rui Y, Ames H, Lugo- Fagundo M, Guerrero-Cazares H, Quiñones-Hinojosa A, Green JJ, Laterra J. A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks. Cancer Res. 2020 Apr 15;80(8):1644-1655. doi: 10.1158/0008-5472.CAN-19-1624. Epub 2020 Feb 24. PMID: 32094299; PMCID:PMC7165043.

    • Marenco-Hillembrand L, Suarez-Meade P, Sabsevitz DS, Leone BJ, Chaichana KL. Awake Craniotomy in a Patient with Previously Diagnosed Post-Traumatic Stress Disorder. World Neurosurg. 2020 Apr 9;139:7-11. doi: 10.1016/j.wneu.2020.03.194. Epub ahead of print. PMID: 32278819.

    • Brown DA, Lu VM, Himes BT, Burns TC, Quiñones-Hinojosa A, Chaichana KL, Parney IF. Breast brain metastases are associated with increased risk of leptomeningeal disease after stereotactic radiosurgery: a systematic review and meta-analysis. Clin Exp Metastasis. 2020 Apr;37(2):341-352. doi:  10.1007/s10585-020-10019-1. Epub 2020 Jan 16. PMID: 31950392.
    • Ko M, Quiñones-Hinojosa A, Rao R. Emerging links between endosomal pH and cancer. Cancer Metastasis Rev. 2020 Jun;39(2):519-534. doi: 10.1007/s10555-020-09870-1. PMID: 32253638; PMCID: PMC7316587.
    • Stross WC, Malouff TD, Waddle MR, Miller RC, Peterson J, Trifiletti DM. Proton beam therapy utilization in adults with primary brain tumors in the United States. J Clin Neurosci. 2020 May;75:112-116. doi: 10.1016/j.jocn.2020.03.011. Epub 2020 Mar 14. PMID: 32184042.
    • Marenco-Hillembrand L, Wijesekera O, Suarez-Meade P, Mampre D, Jackson C, Peterson J, Trifiletti D, Hammack J, Ortiz K, Lesser E, Spiegel M, Prevatt C, Hawayek M, Quinones-Hinojosa A, Chaichana KL. Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis. J Neurooncol. 2020 Apr;147(2):297-307. doi: 10.1007/s11060-020-03451-6. Epub 2020 Mar 9. PMID: 32157552.
    • Anakwenze CP, McGovern S, Taku N, Liao K, Boyce-Fappiano DR, Kamiya-Matsuoka C, Ghia A, Chung C, Trifiletti D, Ferguson SD, Li J, Yeboa DN. Association between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection. World Neurosurg. 2020 May 11:S1878-8750(20)30990-6. doi: 10.1016/j.wneu.2020.05.030. Epub ahead of print.PMID: 32407910.
    • Suarez-Meade P, Marenco-Hillembrand L, Prevatt C, Murguia-Fuentes R, Mohamed A, Alsaeed T, Lehrer EJ, Brigham T, Ruiz-Garcia H, Sabsevitz D, Middlebrooks EH, Bechtle PS, Quinones-Hinojosa A, Chaichana KL. Awake vs. asleep motor mapping for glioma resection: a systematic review and meta-analysis. Acta Neurochir (Wien). 2020 Jul;162(7):1709-1720. doi: 10.1007/s00701-020-04357-y. Epub 2020 May 9. PMID: 32388682.
    • ReFaey K, Tripathi S, Bhargav AG, Grewal SS, Middlebrooks EH, Sabsevitz DS, Jentoft M, Brunner P, Wu A, Tatum WO, Ritaccio A, Chaichana KL, Quinones- Hinojosa A. Potential differences between monolingual and bilingual patients in approach and outcome after awake brain surgery. J Neurooncol. 2020 Jun 10. doi: 10.1007/s11060-020-03554-0. Epub ahead of print. PMID: 32524393.
    • Lehrer EJ, Snyder MH, Desai BD, Li CE, Narayan A, Trifiletti DM, Schlesinger D, Sheehan JP. Clinical and radiographic adverse events after Gamma Knife radiosurgery for brainstem lesions: A dosimetric analysis. Radiother Oncol. 2020 Jun;147:200-209. doi: 10.1016/j.radonc.2020.05.010. Epub 2020 May 13. PMID: 32413528.
    • Gampa G, Kenchappa RS, Mohammad AS, Parrish KE, Kim M, Crish JF, Luu A, West R, Hinojosa AQ, Sarkaria JN, Rosenfeld SS, Elmquist WF. Enhancing Brain Retention of a KIF11 Inhibitor Significantly Improves its Efficacy in a Mouse Model of Glioblastoma. Sci Rep. 2020 Apr 16;10(1):6524. doi: 10.1038/s41598-020-63494-7. PMID: 32300151; PMCID: PMC7162859.
    • Tatum WO, McKay JH, ReFaey K, Feyissa AM, Ryan D, Ritaccio A, Middlebrooks E, Yelvington K, Roth G, Acton E, Grewal S, Chaichana K, Quinones-Hinojosa A. Detection of after-discharges during intraoperative functional brain mapping in awake brain tumor surgery using a novel high-density circular grid. Clin Neurophysiol. 2020 Apr;131(4):828-835. doi: 10.1016/j.clinph.2019.12.416. Epub 2020 Jan 30. PMID: 32066101.
    • Lu VM, Shah AH, Eichberg DG, Quinones-Hinojosa A, Esquenazi Y, Komotar RJ, Ivan ME. Geographic disparities in access to glioblastoma treatment based on Hispanic ethnicity in the United States: Insights from a national database. J Neurooncol. 2020 May;147(3):711-720. doi: 10.1007/s11060-020-03480-1. Epub 2020 Mar 31. PMID: 32236779.

    • Zreik J, Moinuddin FM, Yolcu YU, Alvi MA, Chaichana KL, Quinones-Hinojosa A, Bydon M. Improved 3-year survival rates for glioblastoma multiforme are associated with trends in treatment: analysis of the national cancer database from 2004 to 2013.J Neurooncol. 2020 May;148(1):69-79. doi: 10.1007/s11060-020-03469-w. Epub 2020 May 3. PMID: 32363470.

    • Eichberg DG, Di L, Shah AH, Luther EM, Jackson C, Marenco-Hillembrand L, Chaichana KL, Ivan ME, Starke RM, Komotar RJ. Minimally invasive resection of intracranial lesions using tubular retractors: a large, multi-surgeon, multi- institutional series. J Neurooncol. 2020 Jun 18. doi: 10.1007/s11060-020-03500-0. Epub ahead of print. PMID: 32556805.
  • July – September

    • Ruiz-Garcia H, Huayllani MT, Incontri D, Whaley JJ, Marenco-Hillembrand L, Ebot J, Chaichana KL, Sheehan J, Quiñones-Hinojosa A, Trifiletti DM. Intraventricular choroid plexus tumors: clinical characteristics and impact of current management on survival. J Neurooncol. 2020 Sep 8. doi: 10.1007/s11060-020-03603-8. Epub ahead of print. PMID: 32897467.

    • Suarez-Meade P, Marenco-Hillembrand L, Prevatt C, Murguia-Fuentes R, Mohamed A, Alsaeed T, Lehrer EJ, Brigham T, Ruiz-Garcia H, Sabsevitz D, Middlebrooks EH, Bechtle PS, Quinones-Hinojosa A, Chaichana KL. Awake vs. asleep motor mapping for glioma resection: a systematic review and meta-analysis. Acta Neurochir (Wien). 2020 Jul;162(7):1709-1720. doi: 10.1007/s00701-020-04357-y. Epub 2020 May 9. PMID: 32388682.

    • Lara-Velazquez M, Alkharboosh R, Norton ES, Ramirez-Loera C, Freeman WD, Guerrero-Cazares H, Forte AJ, Quiñones-Hinojosa A, Sarabia-Estrada R. Chitosan-Based Non-viral Gene and Drug Delivery Systems for Brain Cancer. Front Neurol. 2020 Jul 30;11:740. doi: 10.3389/fneur.2020.00740. PMID: 32849207; PMCID: PMC7406673.

    • Al-Kharboosh R, ReFaey K, Lara-Velazquez M, Grewal SS, Imitola J, Quiñones- Hinojosa A. Inflammatory Mediators in Glioma Microenvironment Play a Dual Role in Gliomagenesis and Mesenchymal Stem Cell Homing: Implication for Cellular Therapy. Mayo Clin Proc Innov Qual Outcomes. 2020 Aug 5;4(4):443-459. doi: 10.1016/j.mayocpiqo.2020.04.006. PMID: 32793872; PMCID: PMC7411162.

    • ReFaey K, Tripathi S, Bhargav AG, Grewal SS, Middlebrooks EH, Sabsevitz DS, Jentoft M, Brunner P, Wu A, Tatum WO, Ritaccio A, Chaichana KL, Quinones- Hinojosa A. Potential differences between monolingual and bilingual patients in approach and outcome after awake brain surgery. J Neurooncol. 2020 Jul;148(3):587-598. doi: 10.1007/s11060-020-03554-0. Epub 2020 Jun 10. PMID: 32524393.

    • Brown DA, Goyal A, Kerezoudis P, Alvi MA, Himes BT, Bydon M, Van Gompel JJ, Chaichana KL, Quiñones-Hinojosa A, Burns TC, Yan E, Parney IF. Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry. J Neurooncol. 2020 Aug 28. doi: 10.1007/s11060-020-03604-7. Epub ahead of print. PMID: 32860156.

    • Anakwenze CP, McGovern S, Taku N, Liao K, Boyce-Fappiano DR, Kamiya-Matsuoka C, Ghia A, Chung C, Trifiletti D, Ferguson SD, Li J, Yeboa DN. Association Between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection. World Neurosurg. 2020 Sep;141:e133-e144. doi: 10.1016/j.wneu.2020.05.030. Epub 2020 May 11. PMID: 32407910

    • Horn SR, Stoltzfus KC, Mackley HB, Lehrer EJ, Zhou S, Dandekar SC, Fox EJ, Rizk EB, Trifiletti DM, Rao PM, Zaorsky NG. Long-term causes of death among pediatric patients with cancer. Cancer. 2020 Jul 1;126(13):3102-3113. doi: 10.1002/cncr.32885. Epub 2020 Apr 16. PMID: 32298481.

    • Gui C, Vannorsdall TD, Kleinberg LR, Assadi R, Moore JA, Hu C, Quiñones- Hinojosa A, Redmond KJ. A Prospective Cohort Study of Neural Progenitor Cell- Sparing Radiation Therapy Plus Temozolomide for Newly Diagnosed Patients With Glioblastoma. Neurosurgery. 2020 Jul 1;87(1):E31-E40. doi: 10.1093/neuros/nyaa107. PMID: 32497183; PMCID: PMC7293896.

    • Trifiletti DM, Malouff TD, McGovern SL, Weathers SP, Wang TJC, Lassman AB, Cahill DP, Shih HA, Brown PD. Repeat Radiation in the Brain: Managing Patients With Locally Recurrent Glioma. Semin Radiat Oncol. 2020 Jul;30(3):218-222. doi: 10.1016/j.semradonc.2020.02.005. PMID: 32503786.

    • Marenco-Hillembrand L, Prevatt C, Suarez-Meade P, Ruiz-Garcia H, Quinones- Hinojosa A, Chaichana KL. Minimally Invasive Surgical Outcomes for Deep-Seated Brain Lesions Treated with Different Tubular Retraction Systems: A Systematic Review and Meta-Analysis. World Neurosurg. 2020 Jul 23:S1878-8750(20)31636-3. doi: 10.1016/j.wneu.2020.07.115. Epub ahead of print. PMID: 32712409.

    • Wong BS, Shah SR, Yankaskas CL, Bajpai VK, Wu PH, Chin D, Ifemembi B, ReFaey K, Schiapparelli P, Zheng X, Martin SS, Fan CM, Quiñones-Hinojosa A, Konstantopoulos K. A microfluidic cell-migration assay for the prediction of progression-free survival and recurrence time of patients with glioblastoma. Nat Biomed Eng. 2020 Sep 28. doi: 10.1038/s41551-020-00621-9. Epub ahead of print. PMID: 32989283.

    • Brown DA, Hanalioglu S, Chaichana K, Duffau H. Transcorticosubcortical Approach for Left Posterior Mediobasal Temporal Region Gliomas: A Case Series and Anatomic Review of Relevant White Matter Tracts. World Neurosurg. 2020 Jul;139:e737-e747. doi: 10.1016/j.wneu.2020.04.147. Epub 2020 Apr 29. PMID: 32360919.

    • Qian J, Herman MG, Brinkmann DH, Laack NN, Kemp BJ, Hunt CH, Lowe V, Pafundi Prediction of MGMT Status for Glioblastoma Patients Using Radiomics Feature Extraction From 18F-DOPA-PET Imaging. Int J Radiat Oncol Biol Phys. 2020 Jul 4:S0360-3016(20)31393-6. doi: 10.1016/j.ijrobp.2020.06.073. Epub ahead of print. PMID: 32634544.

    • Marenco-Hillembrand L, Suarez-Meade P, Sabsevitz DS, Leone BJ, Chaichana KL. Awake Craniotomy in a Patient with Previously Diagnosed Post-Traumatic Stress Disorder. World Neurosurg. 2020 Jul;139:7-11. doi: 10.1016/j.wneu.2020.03.194. Epub 2020 Apr 9. PMID: 32278819.

    • Eichberg DG, Di L, Shah AH, Luther EM, Jackson C, Marenco-Hillembrand L, Chaichana KL, Ivan ME, Starke RM, Komotar RJ. Minimally invasive resection of intracranial lesions using tubular retractors: a large, multi-surgeon, multi- institutional series. J Neurooncol. 2020 Aug;149(1):35-44. doi: 10.1007/s11060-020-03500-0. Epub 2020 Jun 18. PMID: 32556805.

    • Ramos-Fresnedo A, Domingo RA, Vivas-Buitrago T, Lundy L, Trifiletti DM, Jentoft ME, Desai AB, Quiñones-Hinojosa A. Multiple meningiomas: does quantity matter? a population-based survival analysis with underlined age and sex differences. J Neurooncol. 2020 Sep 28. doi: 10.1007/s11060-020-03620-7. Epub ahead of print. PMID: 32986140.

    • Toskich BB, Muneer MS, Gopal N, Akinduro OO, Marenco-Hillembrand L, Ritchie C, Miller DA, Middlebrooks EH, Tawk RG. Mapping angiography and transarterial technetium macroaggregated albumin particle simulation of recurrent atypical intracranial meningioma: feasibility for potential vascular brachytherapy. Radiol Case Rep. 2020 Sep 11;15(11):2278-2281. doi: 10.1016/j.radcr.2020.07.051. PMID: 32983300; PMCID: PMC7494606.

Moffitt Cancer Center
  • January – March
    • Sim AJ, Ahmed KA, Keller A, Figura NB, Oliver DE, Sarangkasiri S, Robinson TJ, Johnstone PAS, Yu HM, Naghavi AO. Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases. Am J Clin Oncol. 2020 Mar 24. doi: 10.1097/COC.0000000000000675. [Epub ahead of print] PubMed PMID: 32217854.

    • Ketcher D, Otto AK, Reblin M. Caregivers of Patients With Brain Metastases: A Description of Caregiving Responsibilities and Psychosocial Well-being. J Neurosci Nurs. 2020 Mar 13. doi: 10.1097/JNN.0000000000000500. [Epub ahead of print] PubMed PMID: 32175992.

    • Creed JH, Smith-Warner SA, Gerke TA, Egan KM. A prospective study of coffee and tea consumption and the risk of glioma in the UK Biobank. Eur J Cancer. 2020 Apr;129:123-131. doi: 10.1016/j.ejca.2020.01.012. Epub 2020 Mar 6. PubMed PMID: 32151942.
    • Wick A, Desjardins A, Suarez C, Forsyth P, Gueorguieva I, Burkholder T, Cleverly AL, Estrem ST, Wang S, Lahn MM, Guba SC, Capper D, Rodon J. Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma.Invest New Drugs. 2020 Mar 5. doi: 10.1007/s10637-020-00910-9. [Epub ahead of print] PubMed PMID: 32140889.
    • Gallaher JA, Massey SC, Hawkins-Daarud A, Noticewala SS, Rockne RC, Johnston SK, Gonzalez-Cuyar L, Juliano J, Gil O, Swanson KR, Canoll P, Anderson ARA. From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response. PLoS Comput Biol. 2020 Feb 26;16(2):e1007672. doi: 10.1371/journal.pcbi.1007672. eCollection 2020 Feb. PubMed PMID: 32101537; PubMed Central PMCID: PMC7062288.
    • Mills MN, Figura NB, Arrington JA, Yu HM, Etame AB, Vogelbaum MA, Soliman H, Czerniecki BJ, Forsyth PA, Han HS, Ahmed KA. Management of brain metastases in breast cancer: a review of current practices and emerging treatments. Breast Cancer Res Treat. 2020 Apr;180(2):279-300. doi: 10.1007/s10549-020-05552-2. Epub 2020 Feb 6. Review. PubMed PMID: 32030570.
    • Tan Y, Mu W, Wang XC, Yang GQ, Gillies RJ, Zhang H. Whole-tumor radiomics analysis of DKI and DTI may improve the prediction of genotypes for astrocytomas: A preliminary study. Eur J Radiol. 2020 Mar;124:108785. doi: 10.1016/j.ejrad.2019.108785. Epub 2019 Dec 11. PubMed PMID: 32004731.
    • Chalise P, Ni Y, Fridley BL. Network-based integrative clustering of multiple types of genomic data using non-negative matrix factorization. Comput Biol Med. 2020 Mar;118:103625. doi: 10.1016/j.compbiomed.2020.103625. Epub 2020 Jan 23. PubMed PMID: 31999549; PubMed Central PMCID: PMC7078030.
    • Lee EQ, Weller M, Sul J, Bagley SJ, Sahebjam S, van den Bent M, Ahluwalia M, Campian JL, Galanis E, Gilbert MR, Holdhoff M, Lesser GJ, Lieberman FS, Mehta MP, Penas-Prado M, Schreck KC, Strowd RE, Vogelbaum MA, Walbert T, Chang SM, Nabors LB, Grossman S, Reardon DA, Wen PY. Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients. Neuro Oncol. 2020 Jan 24. pii: noaa015. doi: 10.1093/neuonc/noaa015. [Epub ahead of print] PubMed PMID: 31974566.
    • Drilon A, Siena S, Dziadziuszko R, Barlesi F, Krebs MG, Shaw AT, de Braud F, Rolfo C, Ahn MJ, Wolf J, Seto T, Cho BC, Patel MR, Chiu CH, John T, Goto K, Karapetis CS, Arkenau HT, Kim SW, Ohe Y, Li YC, Chae YK, Chung CH, Otterson GA, Murakami H, Lin CC, Tan DSW, Prenen H, Riehl T, Chow-Maneval E, Simmons B, Cui N, Johnson A, Eng S, Wilson TR, Doebele RC; trial investigators. Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials. Lancet Oncol. 2020 Feb;21(2):261-270. doi: 10.1016/S1470-2045(19)30690-4. Epub 2019 Dec 11. Erratum in: Lancet Oncol. 2020 Feb;21(2):e70. PubMed PMID: 31838015.
    • Rogers CL, Won M, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Fogh SE, Youssef E, Deb N, Kwok Y, Robinson CG, Shu HK, Fisher BJ, Panet-Raymond V, McMillan WG, de Groot JF, Zhang P, Mehta MP. High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539. Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):790-799. doi: 10.1016/j.ijrobp.2019.11.028. Epub 2019 Nov 29. PubMed PMID: 31786276; PubMed Central PMCID: PMC7117785.
    • Sun J, Carr MJ, Khushalani NI. Principles of Targeted Therapy for Melanoma. Surg Clin North Am. 2020 Feb;100(1):175-188. doi: 10.1016/j.suc.2019.09.013. Epub 2019 Nov 1. Review. PubMed PMID: 31753111.
    • Piña Y, Fusco MJ, Macaulay RJ, Walko CM, Peguero E, Evernden BR, Smalley KS, Forsyth P. Using personalized medicine in gliomas: a genomic approach to diagnosis and overcoming treatment resistance in a case with pleomorphic xanthoastrocytoma. J Neurol. 2020 Mar;267(3):783-790. doi: 10.1007/s00415-019-09575-8. Epub 2019 Nov 21. PubMed PMID: 31748891; PubMed Central PMCID: PMC7035305.
    • Chobrutskiy BI, Yeagley M, Tipping P, Zaman S, Diviney A, Patel DN, Falasiri S, Uversky VN, Blanck G. Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma. Oncogene. 2020 Feb;39(8):1773-1783. doi: 10.1038/s41388-019-1101-2. Epub 2019 Nov 18. PubMed PMID: 31740784.
    • Owonikoko TK, Niu H, Nackaerts K, Csoszi T, Ostoros G, Mark Z, Baik C, Joy AA, Chouaid C, Jaime JC, Kolek V, Majem M, Roubec J, Santos ES, Chiang AC, Speranza G, Belani CP, Chiappori A, Patel MR, Czebe K, Byers L, Bahamon B, Li C, Sheldon-Waniga E, Kong EF, Williams M, Badola S, Shin H, Bedford L, Ecsedy JA, Bryant M, Jones S, Simmons J, Leonard EJ, Ullmann CD, Spigel DR; C14018 study investigators. Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses. J Thorac Oncol. 2020 Feb;15(2):274-287. doi: 10.1016/j.jtho.2019.10.013. Epub 2019 Oct 23. PubMed PMID: 31655296.
    • Ostrom QT, Egan KM, Nabors LB, Gerke T, Thompson RC, Olson JJ, LaRocca R, Chowdhary S, Eckel-Passow JE, Armstrong G, Wiencke JK, Bernstein JL, Claus EB, Il’yasova D, Johansen C, Lachance DH, Lai RK, Merrell RT, Olson SH, Sadetzki S, Schildkraut JM, Shete S, Houlston RS, Jenkins RB, Wrensch MR, Melin B, Amos CI, Huse JT, Barnholtz-Sloan JS, Bondy ML. Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics. Int J Cancer. 2020 Feb 1;146(3):739-748. doi: 10.1002/ijc.32318. Epub 2019 Apr 22. PubMed PMID: 30963577; PubMed Central PMCID: PMC6785354.
  • April – June
    • Mills MN, Figura NB, Arrington JA, Yu HM, Etame AB, Vogelbaum MA, Soliman H, Czerniecki BJ, Forsyth PA, Han HS, Ahmed KA. Management of brain metastases in breast cancer: a review of current practices and emerging treatments. Breast Cancer Res Treat. 2020 Apr;180(2):279-300. doi: 10.1007/s10549-020-05552-2. Epub 2020 Feb 6. PMID: 32030570.
    • Lee EQ, Weller M, Sul J, Bagley SJ, Sahebjam S, van den Bent M, Ahluwalia M, Campian JL, Galanis E, Gilbert MR, Holdhoff M, Lesser GJ, Lieberman FS, Mehta MP, Penas-Prado M, Schreck KC, Strowd RE, Vogelbaum MA, Walbert T, Chang SM, Nabors LB, Grossman S, Reardon DA, Wen PY. Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients. Neuro Oncol. 2020 May 15;22(5):601-612. doi: 10.1093/neuonc/noaa015. PMID: 31974566; PMCID: PMC7229255.

    • Sim AJ, Ahmed KA, Keller A, Figura NB, Oliver DE, Sarangkasiri S, Robinson TJ, Johnstone PAS, Yu HM, Naghavi AO. Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases. Am J Clin Oncol. 2020 May;43(5):356-361. doi: 10.1097/COC.0000000000000675. PMID: 32217854.

    • Gadgeel S, Rodríguez-Abreu D, Speranza G, Esteban E, Felip E, Dómine M, Hui R, Hochmair MJ, Clingan P, Powell SF, Cheng SY, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Garon EB, Novello S, Rubio-Viqueira B, Boyer M, Kurata T, Gray JE, Yang J, Bas T, Pietanza MC, Garassino MC. Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer. J Clin Oncol. 2020 May 10;38(14):1505-1517. doi: 10.1200/JCO.19.03136. Epub 2020 Mar 9. PMID: 32150489.

    • Creed JH, Smith-Warner SA, Gerke TA, Egan KM. A prospective study of coffee and tea consumption and the risk of glioma in the UK Biobank. Eur J Cancer. 2020 Apr;129:123-131. doi: 10.1016/j.ejca.2020.01.012. Epub 2020 Mar 6. PMID: 32151942.
    • Rishi A, Yu HM. Current Treatment of Melanoma Brain Metastasis. Curr Treat Options Oncol. 2020 Apr 30;21(6):45. doi: 10.1007/s11864-020-00733-z. PMID: 32350685.
    • Glazar DJ, Grass GD, Arrington JA, Forsyth PA, Raghunand N, Yu HM, Sahebjam S, Enderling H. Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade Glioma. J Clin Med. 2020 Jun 27;9(7):E2019. doi: 10.3390/jcm9072019. PMID: 32605050.
    • Ketcher D, Otto AK, Reblin M. Caregivers of Patients With Brain Metastases: A Description of Caregiving Responsibilities and Psychosocial Well-being. J Neurosci Nurs. 2020 Jun;52(3):112-116. doi: 10.1097/JNN.0000000000000500. PMID: 32175992; PMCID: PMC7196019.
    • Vogelbaum MA, Krivosheya D, Borghei-Razavi H, Sanai N, Weller M, Wick W, Soffietti R, Reardon DA, Aghi MK, Galanis E, Wen PY, van den Bent M, Chang S. Phase 0 and Window of Opportunity Clinical Trial Design in Neuro-Oncology: A RANO Review. Neuro Oncol. 2020 Jun 29:noaa149. doi: 10.1093/neuonc/noaa149. Epub ahead of print. PMID: 32598442.
    • Jiang C, Wallington DG, Anker CJ, Lawson DH, Yushak ML, Kudchadkar RR, Tarhini A, Khan MK. Changing Therapeutic Landscape for Melanoma With Multiple Brain Metastases. Neurosurgery. 2020 Apr 21:nyaa076. doi: 10.1093/neuros/nyaa076. Epub ahead of print. PMID: 32315430.
    • Whitmire P, Rickertsen CR, Hawkins-Daarud A, Carrasco E Jr, Lorence J, De Leon G, Curtin L, Bayless S, Clark-Swanson K, Peeri NC, Corpuz C, Lewis-de Los Angeles CP, Bendok BR, Gonzalez-Cuyar L, Vora S, Mrugala MM, Hu LS, Wang L, Porter A, Kumthekar P, Johnston SK, Egan KM, Gatenby R, Canoll P, Rubin JB, Swanson KR. Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients. BMC Cancer. 2020 May 19;20(1):447. doi: 10.1186/s12885-020-06816-2. PMID: 32429869; PMCID: PMC7238585.
    • Reardon DA, Brandes AA, Omuro A, Mulholland P, Lim M, Wick A, Baehring J, Ahluwalia MS, Roth P, Bähr O, Phuphanich S, Sepulveda JM, De Souza P, Sahebjam S, Carleton M, Tatsuoka K, Taitt C, Zwirtes R, Sampson J, Weller M. Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2020 May 21:e201024. doi: 10.1001/jamaoncol.2020.1024. Epub ahead of print. PMID: 32437507; PMCID: PMC7243167.
    • Ranjbar S, Singleton KW, Jackson PR, Rickertsen CR, Whitmire SA, Clark- Swanson KR, Mitchell JR, Swanson KR, Hu LS. A Deep Convolutional Neural Network for Annotation of Magnetic Resonance Imaging Sequence Type. J Digit Imaging. 2020 Apr;33(2):439-446. doi: 10.1007/s10278-019-00282-4. PMID: 31654174; PMCID: PMC7165226.
    • Ketcher D, Ellington L, Baucom BRW, Clayton MF, Reblin M. “In Eight Minutes We Talked More About Our Goals, Relationship, Than We Have in Years”: A Pilot of Patient-Caregiver Discussions in a Neuro-Oncology Clinic. J Fam Nurs. 2020 May;26(2):126-137. doi: 10.1177/1074840720913963. PMID: 32475300.
    • Fisher BJ, Pugh SL, Macdonald DR, Chakravatri A, Lesser GJ, Fox S, Rogers CL, Werner-Wasik M, Doyle T, Bahary JP, Fiveash JB, Bovi JA, Howard SP, Michael Yu HH, D’Souza D, Laack NN, Barani IJ, Kwok Y, Wahl DR, Strasser JF, Won M, Mehta MP. Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):720-725. doi: 10.1016/j.ijrobp.2020.03.027. Epub 2020 Apr 3. PMID: 32251755.
    • Haider AS, van den Bent M, Wen PY, Vogelbaum MA, Chang S, Canoll PD, Horbinski CM, Huse JT. Toward a standard pathological and molecular characterization of recurrent glioma in adults: a Response Assessment in Neuro- Oncology effort. Neuro Oncol. 2020 Apr 15;22(4):450-456. doi: 10.1093/neuonc/noz233. PMID: 31844891; PMCID: PMC7158649.
    • Alban TJ, Bayik D, Otvos B, Rabljenovic A, Leng L, Jia-Shiun L, Roversi G, Lauko A, Momin AA, Mohammadi AM, Peereboom DM, Ahluwalia MS, Matsuda K, Yun K, Bucala R, Vogelbaum MA, Lathia JD. Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression. Front Immunol. 2020 Jun 18;11:1191. doi: 10.3389/fimmu.2020.01191. PMID: 32625208; PMCID: PMC7315581.
  • July – September

    • Tolaney SM, Sahebjam S, Le Rhun E, Bachelot T, Kabos P, Awada A, Yardley D, Chan A, Conte P, Diéras V, Lin NU, Bear M, Chapman SC, Yang Z, Chen Y, Anders A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast Cancer. Clin Cancer Res. 2020 Jul 21. doi: 10.1158/1078-0432.CCR-20-1764. Epub ahead of print. PMID: 32694159.

    • Prager BC, Vasudevan HN, Dixit D, Bernatchez JA, Wu Q, Wallace LC, Bhargava S, Lee D, King BH, Morton AR, Gimple RC, Pekmezci M, Zhu Z, Siqueira-Neto JL, Wang X, Xie Q, Chen C, Barnett GH, Vogelbaum MA, Mack SC, Chavez L, Perry A, Raleigh DR, Rich JN. The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies. Cancer Discov. 2020 Jul 23:CD-20-0160. doi: 10.1158/2159-8290.CD-20-0160. Epub ahead of print. PMID: 32703768.

    • Glitza IC, Smalley KSM, Brastianos PK, Davies MA, McCutcheon I, Liu JKC, Ahmed KA, Arrington JA, Evernden BR, Smalley I, Eroglu Z, Khushalani N, Margolin K, Kluger H, Atkins MB, Tawbi H, Boire A, Forsyth P. Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions. Pigment Cell Melanoma Res. 2020 Jul;33(4):527-541. doi: 10.1111/pcmr.12861. Epub 2020 Jan 19. PMID: 31916400.

    • Bayik D, Zhou Y, Park C, Hong C, Vail D, Silver DJ, Lauko A, Roversi G, Watson DC, Lo A, Alban TJ, McGraw M, Sorensen M, Grabowski MM, Otvos B, Vogelbaum MA, Horbinski C, Kristensen BW, Khalil AM, Hwang TH, Ahluwalia MS, Cheng F, Lathia JD. Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner. Cancer Discov. 2020 Aug;10(8):1210-1225. doi: 10.1158/2159-8290.CD-19-1355. Epub 2020 Apr 16. PMID: 32300059; PMCID: PMC7415660.

    • Fisher BJ, Pugh SL, Macdonald DR, Chakravatri A, Lesser GJ, Fox S, Rogers CL, Werner-Wasik M, Doyle T, Bahary JP, Fiveash JB, Bovi JA, Howard SP, Michael Yu HH, D’Souza D, Laack NN, Barani IJ, Kwok Y, Wahl DR, Strasser JF, Won M, Mehta Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):720-725. doi: 10.1016/j.ijrobp.2020.03.027. Epub 2020 Apr 3. PMID: 32251755; PMCID: PMC7456814

    • Reardon DA, Brandes AA, Omuro A, Mulholland P, Lim M, Wick A, Baehring J, Ahluwalia MS, Roth P, Bähr O, Phuphanich S, Sepulveda JM, De Souza P, Sahebjam S, Carleton M, Tatsuoka K, Taitt C, Zwirtes R, Sampson J, Weller M. Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2020 Jul 1;6(7):1003-1010. doi: 10.1001/jamaoncol.2020.1024. PMID: 32437507; PMCID: PMC7243167.

    • Dreyfuss LD, Master VA, Raman JD, Spiess PE, Wells SA, Merrill SB, Peyton CC, Sankar D, Sohl B, Patil D, Shapiro DD, Allen GO, Abel EJ. Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma. Urology. 2020 Aug 8:S0090-4295(20)30958-4. doi: 10.1016/j.urology.2020.07.045. Epub ahead of print. PMID: 32781079.

    • Jiang C, Wallington DG, Anker CJ, Lawson DH, Yushak ML, Kudchadkar RR, Tarhini A, Khan MK. Changing Therapeutic Landscape for Melanoma With Multiple Brain Metastases. Neurosurgery. 2020 Sep 1;87(3):498-515. doi: 10.1093/neuros/nyaa076. PMID: 32315430.

    • Keilholz U, Ascierto PA, Dummer R, Robert C, Lorigan P, van Akkooi A, Arance A, Blank CU, Chiarion Sileni V, Donia M, Faries MB, Gaudy-Marqueste C, Gogas H, Grob JJ, Guckenberger M, Haanen J, Hayes AJ, Hoeller C, Lebbé C, Lugowska I, Mandalà M, Márquez-Rodas I, Nathan P, Neyns B, Olofsson Bagge R, Puig S, Rutkowski P, Schilling B, Sondak VK, Tawbi H, Testori A, Michielin O. ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee. Ann Oncol. 2020 Aug 4:S0923-7534(20)39939-7. doi: 10.1016/j.annonc.2020.07.004. Epub ahead of print. PMID: 32763453.

    • Mills MN, Ahmed KA. Miliary breast cancer brain metastasis: a rare and aggressive form of central nervous system metastasis. Br J Cancer. 2020 Aug 4. doi: 10.1038/s41416-020-1001-9. Epub ahead of print. PMID: 32747746.

    • Michielin O, van Akkooi A, Lorigan P, Ascierto PA, Dummer R, Robert C, Arance A, Blank CU, Chiarion Sileni V, Donia M, Faries MB, Gaudy-Marqueste C, Gogas H, Grob JJ, Guckenberger M, Haanen J, Hayes AJ, Hoeller C, Lebbé C, Lugowska I, Mandalà M, Márquez-Rodas I, Nathan P, Neyns B, Olofsson Bagge R, Puig S, Rutkowski P, Schilling B, Sondak VK, Tawbi H, Testori A, Keilholz U. ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee. Ann Oncol. 2020 Aug 4:S0923-7534(20)39940-3. doi: 10.1016/j.annonc.2020.07.005. Epub ahead of print. PMID: 32763452.

    • Grimes DR, Jansen M, Macauley RJ, Scott JG, Basanta D. Evidence for hypoxia increasing the tempo of evolution in glioblastoma. Br J Cancer. 2020 Aug 27. doi: 10.1038/s41416-020-1021-5. Epub ahead of print. PMID: 32848201.

    • Galati MA, Hodel KP, Gams MS, Sudhaman S, Bridge T, Zahurancik WJ, Ungerleider NA, Park VS, Ercan AB, Joksimovic L, Siddiqui I, Siddaway R, Edwards M, de Borja R, Elshaer D, Chung J, Forster VJ, Nunes NM, Aronson M, Wang X, Ramdas J, Seeley A, Sarosiek T, Dunn GP, Byrd JN, Mordechai O, Durno C, Martin A, Shlien A, Bouffet E, Suo Z, Jackson JG, Hawkins CE, Guidos CJ, Pursell ZF, Tabori U. Cancers from novel Pole mutant mouse models provide insights into polymerase-mediated hypermutagenesis and immune checkpoint blockade. Cancer Res. 2020 Sep 16:canres.0624.2020. doi: 10.1158/0008-5472.CAN-20-0624. Epub ahead of print. PMID: 32938641.

    • Okten IN, Ismail S, Withycombe BM, Eroglu Z. Preclinical discovery and clinical development of encorafenib for the treatment of melanoma. Expert Opin Drug Discov. 2020 Jul 28:1-8. doi: 10.1080/17460441.2020.1795124. Epub ahead of print. PMID: 32720533.

    • Slagowski JM, Redler G, Malin MJ, Cammin J, Lobb EC, Lee BH, Sethi A, Roeske JC, Flores-Martinez E, Stevens T, Yenice KM, Green O, Mutic S, Aydogan B. Dosimetric feasibility of brain stereotactic radiosurgery with a 0.35 T MRI- guided linac and comparison versus a C-arm mounted linac. Med Phys. 2020 Sep 30. doi: 10.1002/mp.14503. Epub ahead of print. PMID: 32996591.

Cleveland Clinic, Florida
  • January – September

    • Samadian M, Sharifi G, Mousavinejad SA, Amin AA, Ebrahimzadeh K, Tavassol HH, Borghei-Razavi H, Rezaei O. Surgical Outcomes of Sphenoorbital En Plaque Meningioma: A 10-Year Experience in 57 Consecutive Cases. World Neurosurg. 2020 Sep 8:S1878-8750(20)32010-6. doi: 10.1016/j.wneu.2020.09.002. Epub ahead of print. PMID: 32916364.

2019 Publications

The following articles were published in 2019 and were written by research faculty at Florida partner institutions or collaborators who are members of FCBTR. The listing is from PubMed which is a free resource that is developed and maintained by the National Center for Biotechnology Information (NCBI), at the U.S. National Library of Medicine (NLM), located at the National Institutes of Health (NIH). Institutions included here are University of Florida, University of Miami, Mayo Clinic, Florida, Moffitt Cancer Center.

Please use the drop down menu to see the publications for each institution. 

University of Florida
  •  Balis FM, Busch CM, Desai AV, Hibbitts E, Naranjo A, Bagatell R, Irwin M, Fox E. The ganglioside G(D2) as a circulating tumor biomarker for neuroblastoma. Pediatr Blood Cancer. 2020 Jan;67(1):e28031. doi: 10.1002/pbc.28031. Epub 2019 Oct 14. PubMed PMID: 31612589.
  • Li BK, Vasiljevic A, Dufour C, Yao F, Ho BLB, Lu M, Hwang EI, Gururangan S, Hansford JR, Fouladi M, Nobusawa S, Laquerriere A, Delisle MB, Fangusaro J, Forest F, Toledano H, Solano-Paez P, Leary S, Birks D, Hoffman LM, Szathmari A, Faure-Conter C, Fan X, Catchpoole D, Zhou L, Schultz KAP, Ichimura K, Gauchotte G, Jabado N, Jones C, Loussouarn D, Mokhtari K, Rousseau A, Ziegler DS, Tanaka S, Pomeroy SL, Gajjar A, Ramaswamy V, Hawkins C, Grundy RG, Hill DA, Bouffet E, Huang A, Jouvet A. Pineoblastoma segregates into molecular sub-groups distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study. Acta Neuropathol. 2019 Dec 9. doi: 10.1007/s00401-019-02111-y. [Epub aheadof print] PubMed PMID: 31820118.
  • Liu APY, Gudenas B, Lin T, Orr BA, Klimo P Jr, Kumar R, Bouffet E, Gururangan S, Crawford JR, Kellie SJ, Chintagumpala M, Fisher MJ, Bowers DC, Hassall T, Indelicato DJ, Onar-Thomas A, Ellison DW, Boop FA, Merchant TE, Robinson GW, Northcott PA, Gajjar A. Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathol. 2019 Dec 4. doi: 10.1007/s00401-019-02106-9. [Epub ahead of print] PubMed PMID: 31802236.
  • Grippin AJ, Wummer B, Wildes T, Dyson K, Trivedi V, Yang C, Sebastian M, Mendez-Gomez HR, Padala S, Grubb M, Fillingim M, Monsalve A, Sayour EJ, Dobson J, Mitchell DA. Dendritic Cell-Activating Magnetic Nanoparticles Enable Early Prediction of Antitumor Response with Magnetic Resonance Imaging. ACS Nano. 2019 Dec 2. doi: 10.1021/acsnano.9b05037. [Epub ahead of print] PubMed PMID: 31730332.
  •  Matsumoto S, Yonai S, Bolch WE. Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy: Organ doses in pediatric brain tumor treatment. MedPhys. 2019 Dec;46(12):5824-5832. doi: 10.1002/mp.13864. Epub 2019 Oct 29. PubMed PMID: 31603561.
  •  Flores C, Wildes T, Dean BD, Moore G, Drake J, Abraham R, Gil J, Yegorov O, Yang C, Dean J, Moneypenny C, Shin D, Pham C, Krauser J, King J, Grant G, Driscoll T, Kurtzberg J, McLendon R, Gururangan S, Mitchell D. Massive clonal expansion of medulloblastoma-specific T cells during adoptive cellular therapy. Sci Adv. 2019 Nov 27;5(11):eaav9879. doi: 10.1126/sciadv.aav9879. eCollection 2019 Nov. PubMed PMID: 31807694; PubMed Central PMCID: PMC6881165.
  • Dastmalchi F, Karachi A, Yang C, Azari H, Sayour EJ, Dechkovskaia A, Vlasak AL, Saia ME, Lovaton RE, Mitchell DA, Rahman M. Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling. J Immunother Cancer. 2019 Nov 21;7(1):321. doi: 10.1186/s40425-019-0809-4. PubMed PMID: 31753028.
  • Amaral SDC, Barbieri SF, Ruthes AC, Bark JM, Brochado Winnischofer SM, Silveira JLM. Cytotoxic effect of crude and purified pectins from Campomanesia xanthocarpa Berg on human glioblastoma cells. Carbohydr Polym. 2019 Nov 15;224:115140. doi: 10.1016/j.carbpol.2019.115140. Epub 2019 Aug 2. PubMed PMID: 31472853.
  •  Long Y, Tao H, Karachi A, Grippin AJ, Jin L, Chang YE, Zhang W, Dyson KA, Hou AY, Na M, Deleyrolle LP, Sayour EJ, Rahman M, Mitchell DA, Lin Z, Huang J.Dysregulation of glutamate transport enhances Treg function that promotes VEGF blockade resistance in glioblastoma. Cancer Res. 2019 Nov 13. pii: canres.1577.2019. doi: 10.1158/0008-5472.CAN-19-1577. [Epub ahead of print] PubMed PMID: 31723000.
  • Gu T, Zhao X. Integrating multi-platform genomic datasets for kidney renal clear cell carcinoma subtyping using stacked denoising autoencoders. Sci Rep. 2019 Nov 13;9(1):16668. doi: 10.1038/s41598-019-53048-x. PubMed PMID: 31723226; PubMed Central PMCID: PMC6853929.
  • Lawell MP, Indelicato DJ, Paulino AC, Hartsell W, Laack NN, Ermoian RP, Perentesis JP, Vatner R, Perkins S, Mangona VS, Hill-Kayser CE, Wolden SL, Kwok, y Chang JH, Wilkinson JB, MacEwan I, Chang AL, Eaton BR, Ladra MM, Gallotto SL, Weyman EA, Bajaj BVM, Baliga S, Yeap BY, Berrington de Gonzalez A, Yock TI. An open invitation to join the Pediatric Proton/Photon Consortium Registry to standardize data collection in pediatric radiation oncology. Br J Radiol. 2019 Nov 1:20190673. doi: 10.1259/bjr.20190673. [Epub ahead of print] PubMed PMID: 31600082.
  • Pusey MA, Pace K, Fascelli M, Linser PJ, Steindler DA, Galileo DS. Ectopic expression of L1CAM ectodomain alters differentiation and motility, but not proliferation, of human neural progenitor cells. Int J Dev Neurosci. 2019 Nov;78:49-64. doi: 10.1016/j.ijdevneu.2019.08.001. Epub 2019 Aug 14. PubMed PMID: 31421150.
  • Crabtree VM, Klages KL, Sykes A, Wise MS, Lu Z, Indelicato D, Merchant TE, Avent Y, Mandrell BN. Sensitivity and Specificity of the Modified Epworth Sleepiness Scale in Children With Craniopharyngioma. J Clin Sleep Med. 2019 Oct15;15(10):1487-1493. doi: 10.5664/jcsm.7982. PubMed PMID: 31596214; PubMed Central PMCID: PMC6778340.
  • Jin D, Tran N, Thomas N, Tran DD. Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity. PLoS One. 2019 Oct 10;14(10):e0223555. doi: 10.1371/journal.pone.0223555. eCollection 2019. PubMed PMID: 31600301; PubMed Central PMCID: PMC6786609.
  • Upadhyaya SA, Robinson GW, Onar-Thomas A, Orr BA, Billups CA, Bowers DC, Bendel AE, Hassall T, Crawford JR, Partap S, Fisher PG, Tatevossian RG, Seah T, Qaddoumi IA, Vinitsky A, Armstrong GT, Sabin ND, Tinkle CL, Klimo P, Indelicato DJ, Boop FA, Merchant TE, Ellison DW, Gajjar A. Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial. Neuro Oncol. 2019 Oct 9;21(10):1319-1330. doi: 10.1093/neuonc/noz069. PubMed PMID: 30976811; PubMed Central PMCID: PMC6784269.
  • Sood D, Tang-Schomer M, Pouli D, Mizzoni C, Raia N, Tai A, Arkun K, Wu J, Black LD 3rd, Scheffler B, Georgakoudi I, Steindler DA, Kaplan DL. 3D extracellular matrix microenvironment in bioengineered tissue models of primarypediatric and adult brain tumors. Nat Commun. 2019 Oct 4;10(1):4529. doi: 10.1038/s41467-019-12420-1. PubMed PMID: 31586101; PubMed Central PMCID PMC6778192.
  • Stokkevåg CH, Indelicato DJ, Herfarth K, Magelssen H, Evensen ME, Ugland M, Nordberg T, Nystad TA, Hægeland C, Alsaker MD, Ulven K, Dale JE, Engeseth GM, Boer CG, Toussaint L, Kornerup JS, Pettersen HES, Brydøy M, Brandal P, Muren LP. Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy. Acta Oncol. 2019 Oct;58(10):1416-1422. doi: 10.1080/0284186X.2019.1643496. Epub 2019 Jul 31. PubMed PMID: 31364899
  • Toussaint L, Indelicato DJ, Holgersen KS, Petersen JBB, Stokkevåg CH, Lassen-Ramshad Y, Casares-Magaz O, Vestergaard A, Muren LP. Towards proton arc therapy: physical and biologically equivalent doses with increasing number of beams in pediatric brain irradiation. Acta Oncol. 2019 Oct;58(10):1451-1456. doi:10.1080/0284186X.2019.1639823. Epub 2019 Jul 15. PubMed PMID: 31303090.
  • Toussaint L, Indelicato DJ, Stokkevåg CH, Lassen-Ramshad Y, Pedro C, Mikkelsen R, Di Pinto M, Li Z, Flampouri S, Vestergaard A, Petersen JBB, Schrøder H, Høyer M, Muren LP. Radiation doses to brain substructures associated with cognition in radiotherapy of pediatric brain tumors. Acta Oncol. 2019 Oct;58(10):1457-1462. doi: 10.1080/0284186X.2019.1629014. Epub 2019 Jul 4. PubMed PMID: 31271084.
  • Hutchison S, Sahay B, de Mello SC, Sayour EJ, Lejeune A, Szivek A, Livaccari  AM, Fox-Alvarez S, Salute M, Powers L, Milner RJ. Characterization of myeloid-derived suppressor cells and cytokines GM-CSF, IL-10 and MCP-1 in dogs with malignant melanoma receiving a GD3-based immunotherapy. Vet Immunol Immunopathol. 2019 Oct;216:109912. doi: 10.1016/j.vetimm.2019.109912. Epub 2019 Jul 31. PubMed PMID: 31446208.
  • Jin L, Tao H, Karachi A, Long Y, Hou AY, Na M, Dyson KA, Grippin AJ, Deleyrolle LP, Zhang W, Rajon DA, Wang QJ, Yang JC, Kresak JL, Sayour EJ, Rahman  M, Bova FJ, Lin Z, Mitchell DA, Huang J. CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors. Nat Commun. 2019 Sep 5;10(1):4016. doi: 10.1038/s41467-019-11869-4. PubMed PMID: 31488817; PubMed Central PMCID: PMC6728370.
  • Toussaint L, Indelicato DJ, Muren LP, Li Z, Lassen-Ramshad Y, Kirby K, Pedro C, Mikkelsen R, Di Pinto M, Høyer M, Stokkevåg CH. Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma. Radiother Oncol. 2019 Aug 28. pii: S0167-8140(19)33041-5. doi: 10.1016/j.radonc.2019.08.002. [Epub ahead of print]PubMed PMID: 31472997.
  • O’steen L, Amdur RJ, Morris CG, Mendenhall WM. Challenging the concept that late recurrence and death from tumor are common after fractionated radiotherapy for benign meningioma. Radiother Oncol. 2019 Aug;137:55-60. doi: 10.1016/j.radonc.2019.04.017. Epub 2019 May 6. PubMed PMID: 31071515.
  • Laurent D, Freedman R, Cope L, Sacks P, Abbatematteo J, Kubilis P, Bova F, Rahman M. Impact of Extent of Resection on Incidence of Postoperative Complications in Patients With Glioblastoma. Neurosurgery. 2019 Jul 25. pii: nyz313. doi: 10.1093/neuros/nyz313. [Epub ahead of print] PubMed PMID: 31342060.
  • Dyson KA, Stover BD, Grippin A, Mendez-Gomez HR, Lagmay J, Mitchell DA, Sayour EJ. Emerging trends in immunotherapy for pediatric sarcomas. J Hematol Oncol. 2019 Jul 16;12(1):78. doi: 10.1186/s13045-019-0756-z. Review. PubMed PMID: 31311607; PubMed Central PMCID: PMC6636007.
  • Morley CD, Ellison ST, Bhattacharjee T, O’Bryan CS, Zhang Y, Smith KF, Kabb CP, Sebastian M, Moore GL, Schulze KD, Niemi S, Sawyer WG, Tran DD, Mitchell DA,  Sumerlin BS, Flores CT, Angelini TE. Quantitative characterization of 3D bioprinted structural elements under cell generated forces. Nat Commun. 2019 Jul  10;10(1):3029. doi: 10.1038/s41467-019-10919-1. PubMed PMID: 31292444; PubMed Central PMCID: PMC6620298.
  • Arscott WT, Zhu S, Plastaras JP, Maity A, Alonso-Basanta M, Jones J. Acute neurologic toxicity of palliative radiotherapy for brain metastases in patients receiving immune checkpoint blockade. Neurooncol Pract. 2019 Jul;6(4):297-304. doi: 10.1093/nop/npy042. Epub 2018 Oct 25. PubMed PMID: 31386046; PubMed Central  PMCID: PMC6660815.
  • Karachi A, Yang C, Dastmalchi F, Sayour EJ, Huang J, Azari H, Long Y, Flores  C, Mitchell DA, Rahman M. Modulation of temozolomide dose differentially affects  T-cell response to immune checkpoint inhibition. Neuro Oncol. 2019 Jun 10;21(6):730-741. doi: 10.1093/neuonc/noz015. PubMed PMID: 30668768; PubMed Central PMCID: PMC6556847.
  • Hu M, Tang Y, Long G, Zhang D, Kresak JL, Lai J. Primary Extracranial Meningioma of Mastoid in a Patient With History of Skin Squamous Cell Carcinoma,  Lung Adenocarcinoma and Prostatic Carcinoma. Anticancer Res. 2019 Jun;39(6):3197-3201. doi: 10.21873/anticanres.13458. PubMed PMID: 31177167.
  • Jones T, Zhang B, Major S, Webb A. All-trans retinoic acid eluting poly(diol  citrate) wafers for treatment of glioblastoma. J Biomed Mater Res B Appl Biomater. 2019 May 14. doi: 10.1002/jbm.b.34416. [Epub ahead of print] PubMed PMID: 31087625.
  • Indelicato DJ, Rotondo RL, Uezono H, Sandler ES, Aldana PR, Ranalli NJ, Beier AD, Morris CG, Bradley JA. Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma. Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):149-156. doi: 10.1016/j.ijrobp.2019.01.078. Epub 2019 Jan 23. PubMed PMID: 30684665.
  • Magdoom KN, Delgado F, Bohórquez AC, Brown AC, Carney PR, Rinaldi C, Mareci TH, Ewing JR, Sarntinoranont M. Longitudinal evaluation of tumor microenvironment in rat focal brainstem glioma using diffusion and perfusion MRI. J Magn Reson Imaging. 2019 May;49(5):1322-1332. doi: 10.1002/jmri.26315. Epub 2018 Oct 14. PubMed PMID: 30318760.
  • Kissoon T, Gururangan S, Sladky J. Acute neurotoxicity following vincristine  due to Charcot-Marie-Tooth disease in a young child with medulloblastoma. Neurooncol Pract. 2019 May;6(3):179-184. doi: 10.1093/nop/npz002. Epub 2019 Mar 18. PubMed PMID: 31385990; PubMed Central PMCID: PMC6656327.
  • Pohl-Guimarães F, Yang C, Dyson KA, Wildes TJ, Drake J, Huang J, Flores C, Sayour EJ, Mitchell DA. RNA-Modified T Cells Mediate Effective Delivery of Immunomodulatory Cytokines to Brain Tumors. Mol Ther. 2019 Apr 10;27(4):837-849.  doi: 10.1016/j.ymthe.2018.10.007. Epub 2018 Oct 17. PubMed PMID: 30448196; PubMed Central PMCID: PMC6453546.
  • Decker M, Sacks P, Abbatematteo J, De Leo E, Brennan M, Rahman M. The effects of hyperglycemia on outcomes in surgical high-grade glioma patients. Clin Neurol  Neurosurg. 2019 Apr;179:9-13. doi: 10.1016/j.clineuro.2019.02.011. Epub 2019 Feb  11. PubMed PMID: 30784896.
  • Conklin HM, Ness KK, Ashford JM, Scoggins MA, Ogg RJ, Han Y, Li Y, Bradley JA, Boop FA, Merchant TE. Cognitive Performance, Aerobic Fitness, Motor Proficiency, and Brain Function Among Children Newly Diagnosed With Craniopharyngioma. J Int Neuropsychol Soc. 2019 Apr;25(4):413-425. doi: 10.1017/S1355617718001170. PubMed PMID: 31050329; PubMed Central PMCID: PMC6499492.
  • Cooper BT, Bradley JA. Chemotherapy to Spare Cognition. Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):544-545. doi: 10.1016/j.ijrobp.2018.10.040. PubMed PMID: 30722967.
  • Wildes TJ, Grippin A, Fasanya H, Dyson KA, Brantly M. Effect of atorvastatin  on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: The StatVax randomized clinical trial. Vaccine. 2019 Feb 28;37(10):1313-1324. doi: 10.1016/j.vaccine.2019.01.023. Epub 2019 Jan 25. PubMed PMID: 30686636; PubMed Central PMCID: PMC6379110.
  • Sarkisian MR, Semple-Rowland SL. Emerging Roles of Primary Cilia in Glioma. Front Cell Neurosci. 2019 Feb 20;13:55. doi: 10.3389/fncel.2019.00055. eCollection 2019. Review. PubMed PMID: 30842728; PubMed Central PMCID: PMC6391589.
  • Müller HL, Merks JHM, Geoerger B, Grill J, Hargrave D, Glade Bender J, Gururangan S, Navid F, Johnston M, Bachir J, Elze MC, Fürst-Recktenwald S. Integrated analysis of long-term growth and bone development in pediatric and adolescent patients receiving bevacizumab. Pediatr Blood Cancer. 2019 Feb;66(2):e27487. doi: 10.1002/pbc.27487. Epub 2018 Oct 30. PubMed PMID: 30378286.
  • Wildes TJ, Flores CT, Mitchell DA. Concise Review: Modulating Cancer Immunity with Hematopoietic Stem and Progenitor Cells. Stem Cells. 2019 Feb;37(2):166-175.  doi: 10.1002/stem.2933. Epub 2018 Nov 12. Review. PubMed PMID: 30353618; PubMed Central PMCID: PMC6368859.
  • Hicks J, Platt S, Stewart G, Senneca C, Holmes S, Kent M, Howerth E, Kaplan J, Kaplan E. Intratumoral temozolomide in spontaneous canine gliomas: feasibility of a novel therapy using implanted microcylinders. Vet Med Sci. 2019 Feb;5(1):5-18. doi: 10.1002/vms3.124. Epub 2018 Nov 5. PubMed PMID: 30394686; PubMed Central PMCID: PMC6376143.
  • Robson JP, Remke M, Kool M, Julian E, Korshunov A, Pfister SM, Osborne GW, Taylor MD, Wainwright B, Reynolds BA. Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells. PLoS One. 2019 Jan 18;14(1):e0210665. doi: 10.1371/journal.pone.0210665. eCollection 2019.  PubMed PMID: 30657775; PubMed Central PMCID: PMC6338368.
  • Abu Arja MH, Stalling M, Governale LS, Pierson CR, Rusin JA, Palmer JD, Finlay JL, Olshefski R, Boué DR. Germinoma Involving the Retina: An Unusual Presentation of Recurrent Intracranial Mixed Germ Cell Tumor. World Neurosurg. 2019 Jan 7. pii: S1878-8750(19)30002-6. doi: 10.1016/j.wneu.2018.12.143. [Epub ahead of print] PubMed PMID: 30630044.
  • Wei J, Ma L, Li C, Pierson CR, Finlay JL, Lin J. Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells. Curr Cancer Drug Targets. 2019;19(7):571-582. doi: 10.2174/1568009618666181016165604. PubMed PMID: 30332965; PubMed Central PMCID: PMC6533162.
  • Boulle G, Bracci S, Hitchcock K, Jacob J, Clausse E, Halley A, Belghith B, Kamsu Kom L, Canova CH, Bielle F, Chevalier A, Peyre M, Mazeron JJ, Maingon P, Feuvret L. Treatment of grade II-III intracranial meningioma with helical tomotherapy. J Clin Neurosci. 2019 Jan;59:190-196. doi: 10.1016/j.jocn.2018.10.073. Epub 2018 Oct 24. PubMed PMID: 30528356.
  • Zoll WM, Miller AD, Bandt C, Abbott JR. Primary leptomeningeal gliomatosis in a domestic shorthaired cat. J Vet Diagn Invest. 2019 Jan;31(1):94-97. doi: 10.1177/1040638718822683. PubMed PMID: 30803413; PubMed Central PMCID: PMC6505755.
  • Seibel NL, Chi YY, Perlman EJ, Tian J, Sun J, Anderson JR, Ritchey ML, Thomas PR, Miser J, Kalapurakal JA, Grundy PE, Green DM. Impact of cyclophosphamide and  etoposide on outcome of clear cell sarcoma of the kidney treated on the National  Wilms Tumor Study-5 (NWTS-5). Pediatr Blood Cancer. 2019 Jan;66(1):e27450. doi: 10.1002/pbc.27450. Epub 2018 Sep 25. PubMed PMID: 30255545; PubMed Central PMCID: PMC6249042.
  •  Rahman M, Dastmalchi F, Karachi A, Mitchell D. The role of CMV in glioblastoma and implications for immunotherapeutic strategies. Oncoimmunology. 2018 Oct 16;8(1):e1514921. doi: 10.1080/2162402X.2018.1514921. eCollection 2019.  Review. PubMed PMID: 30546954; PubMed Central PMCID: PMC6287786.
</details
University of Miami
  • Eichberg DG, Menaker SA, Jermakowicz WJ, Shah AH, Luther EM, Jamshidi AM, Semonche AM, Di L, Komotar RJ, Ivan ME. Multiple Iterations of Magnetic Resonance-Guided Laser Interstitial Thermal Ablation of Brain Metastases: Single Surgeon’s Experience and Review of the Literature. Oper Neurosurg (Hagerstown). 2019 Dec 12. pii: opz384. doi: 10.1093/ons/opz375. [Epub ahead of print] PubMed PMID: 31828344.
  • Eichberg DG, Shah AH, Di L, Semonche AM, Jimsheleishvili G, Luther EM, SarkissCA, Levi AD, Gultekin SH, Komotar RJ, Ivan ME. Stimulated Raman histology forrapid and accurate intraoperative diagnosis of CNS tumors: prospective blindedstudy. J Neurosurg. 2019 Dec 6:1-7. doi: 10.3171/2019.9.JNS192075. [Epub ahead ofprint] PubMed PMID: 31812144.
  • Luther E, Matus A, Eichberg DG, Shah AH, Ivan M. Stimulated Raman Histologyfor Intraoperative Guidance in the Resection of a Recurrent AtypicalSpheno-orbital Meningioma: A Case Report and Review of Literature. Cureus. 2019Oct 14;11(10):e5905. doi: 10.7759/cureus.5905. PubMed PMID: 31777692; PubMedCentral PMCID: PMC6853273.
  • Shah AH, Semonche A, Eichberg DG, Borowy V, Luther E, Sarkiss CA, Morell A,Mahavadi AK, Ivan ME, Komotar RJ. The Role of Laser Interstitial Thermal Therapy in Surgical Neuro-Oncology: Series of 100 Consecutive Patients. Neurosurgery.2019 Nov 19. pii: nyz424. doi: 10.1093/neuros/nyz424. [Epub ahead of print]PubMed PMID: 31742351.
  • Epstein RH, Dexter F, Cajigas I, Mahavadi AK, Shah AH, Abitbol N, Komotar RJ.Prolonged tracheal extubation time after glioma surgery was associated with lack of familiarity between the anesthesia provider and the operating neurosurgeon. A retrospective, observational study. J Clin Anesth. 2020 Mar;60:118-124. doi:10.1016/j.jclinane.2019.09.003. Epub 2019 Oct 24. PubMed PMID: 31669746.
  • Cajigas I, Mahavadi AK, Shah AH, Borowy V, Abitbol N, Ivan ME, Komotar RJ,Epstein RH. Analysis of intra-operative variables as predictors of 30-dayreadmission in patients undergoing glioma surgery at a single center. JNeurooncol. 2019 Dec;145(3):509-518. doi: 10.1007/s11060-019-03317-6. Epub 2019Oct 22. PubMed PMID: 31642024.
  • Mahtani R, Hineman L. Advances in HER2-Positive Breast Cancer: NovelTherapies and Adverse Event Management. J Adv Pract Oncol. 2019Mar;10(2):136-153. Epub 2019 Mar 1. Review. PubMed PMID: 31538025; PubMed CentralPMCID: PMC6750923.
  • Ripa V, Kwon CS, Burks JD, Morcos JJ. Neuro-Behcet Disease Mimicking LymphomaOf the Brain and Coexisting with A Dural Arteriovenous Fistula: A Case Report.World Neurosurg. 2019 Sep 13;133:205-211. doi: 10.1016/j.wneu.2019.09.035. [Epubahead of print] PubMed PMID: 31525480.
  • Wang J, Foley M, Kuker R. Pituitary Adenoma on 18F-Fluciclovine PET/CT. ClinNucl Med. 2020 Jan;45(1):e65-e66. doi: 10.1097/RLU.0000000000002777. PubMed PMID:31524674.
  • Eichberg DG, Di L, Shah AH, Luther E, Richardson AM, Sarkiss CA, Ivan ME,Komotar RJ. Brain Tumor Surgery is Safe in Octogenarians and Nonagenarians: ASingle-Surgeon 741 Patient Series. World Neurosurg. 2019 Dec;132:e185-e192. doi:10.1016/j.wneu.2019.08.219. Epub 2019 Sep 7. PubMed PMID: 31505286.
  • Halfpenny A, Ferris SP, Grafe M, Woltjer R, Selden N, Nazemi K, Perry A,Solomon DA, Gultekin SH, Moore S, Olson S, Lawce H, Lucas L, Corless CL, Wood MD.A case of recurrent epilepsy-associated rosette-forming glioneuronal tumor withanaplastic transformation in the absence of therapy. Neuropathology. 2019Oct;39(5):389-393. doi: 10.1111/neup.12586. Epub 2019 Aug 21. PubMed PMID:31435988; PubMed Central PMCID: PMC6852525.
  • Thakur VS, Aguila B, Brett-Morris A, Creighton CJ, Welford SM.Spermidine/spermine N1-acetyltransferase 1 is a gene-specific transcriptionalregulator that drives brain tumor aggressiveness. Oncogene. 2019Oct;38(41):6794-6800. doi: 10.1038/s41388-019-0917-0. Epub 2019 Aug 9. PubMedPMID: 31399646; PubMed Central PMCID: PMC6786946.
  • Aguila B, Morris AB, Spina R, Bar E, Schraner J, Vinkler R, Sohn JW, Welford glioblastoma multiforme. Cancer Lett. 2019 Oct 10;462:33-42. doi:10.1016/j.canlet.2019.07.018. Epub 2019 Aug 1. PubMed PMID: 31377205; PubMedCentral PMCID: PMC6705426.
  • Gersey Z, Osiason AD, Bloom L, Shah S, Thompson JW, Bregy A, Agarwal N,Komotar RJ. Therapeutic Targeting of the Notch Pathway in GlioblastomaMultiforme. World Neurosurg. 2019 Nov;131:252-263.e2. doi:10.1016/j.wneu.2019.07.180. Epub 2019 Jul 31. Review. PubMed PMID: 31376551.
  • Eichberg DG, Richardson AM, Brusko GD, Ali SC, Buttrick SS, Shah AH, Alam ES,Sargi ZB, Komotar RJ. The use of dehydrated amniotic membrane allograft foraugmentation of dural repair in transsphenoidal endoscopic endonasal resection ofpituitary adenomas. Acta Neurochir (Wien). 2019 Oct;161(10):2117-2122. doi:10.1007/s00701-019-04008-x. Epub 2019 Aug 1. PubMed PMID: 31372758.
  • Mahavadi AK, Shah AH, Komotar RJ. Commentary: Optimizing PostoperativeSurveillance of Pediatric Low-Grade Glioma Using Tumor Behavior Patterns. Neurosurgery. 2019 Apr 24. pii: nyz124. doi: 10.1093/neuros/nyz124. [Epub aheadof print] PubMed PMID: 31329955.
  • Wang EW, Zanation AM, Gardner PA, Schwartz TH, Eloy JA, Adappa ND, Bettag M,Bleier BS, Cappabianca P, Carrau RL, Casiano RR, Cavallo LM, Ebert CS Jr,El-Sayed IH, Evans JJ, Fernandez-Miranda JC, Folbe AJ, Froelich S, Gentili F,Harvey RJ, Hwang PH, Jane JA Jr, Kelly DF, Kennedy D, Knosp E, Lal D, Lee JYK,Liu JK, Lund VJ, Palmer JN, Prevedello DM, Schlosser RJ, Sindwani R, Solares CA,Tabaee A, Teo C, Thirumala PD, Thorp BD, de Arnaldo Silva Vellutini E, WitterickI, Woodworth BA, Wormald PJ, Snyderman CH. ICAR: endoscopic skull-base surgery.Int Forum Allergy Rhinol. 2019 Jul;9(S3):S145-S365. doi: 10.1002/alr.22326. PubMed PMID: 31329374.
  • Semonche A, Shah AH, Ivan ME, Komotar RJ. Towards a microRNA-based GeneTherapy for Glioblastoma. Neurosurgery. 2019 Aug 1;85(2):E210-E211. doi:10.1093/neuros/nyz166. PubMed PMID: 31304544.
  • Penas C, Maloof ME, Stathias V, Long J, Tan SK, Mier J, Fang Y, Valdes C,Rodriguez-Blanco J, Chiang CM, Robbins DJ, Liebl DJ, Lee JK, Hatten ME, Clarke J,Ayad NG. Time series modeling of cell cycle exit identifies Brd4 dependentregulation of cerebellar neurogenesis. Nat Commun. 2019 Jul 10;10(1):3028. doi:10.1038/s41467-019-10799-5. PubMed PMID: 31292434; PubMed Central PMCID:PMC6620341.
  • Eichberg DG, Casabella AM, Menaker SA, Shah AH, Komotar RJ. Parasagittal and parafalcine meningiomas: integral strategy for optimizing safety andretrospective review of a single surgeon series. Br J Neurosurg. 2019 Jul 9:1-6.doi: 10.1080/02688697.2019.1635988. [Epub ahead of print] PubMed PMID: 31284785.
  • Jermakowicz WJ, Mahavadi AK, Cajigas I, Dan L, Guerra S, Farooq G, Shah AH,D’Haese PF, Ivan ME, Jagid JR, Komotar RJ. Predictive modeling of brain tumorlaser ablation dynamics. J Neurooncol. 2019 Aug;144(1):193-203. doi:10.1007/s11060-019-03220-0. Epub 2019 Jun 25. PubMed PMID: 31240526.
  • Zenonos GA, Morcos JJ. Occipital to Angular Artery Bypass forPost-irradiation Ischemia: 3-Dimensional Operative Video. Oper Neurosurg(Hagerstown). 2019 Jun 7. pii: opz125. doi: 10.1093/ons/opz125. [Epub ahead ofprint] PubMed PMID: 31173139.
  • Munich SA, Morcos JJ. Petrous Apex Meningioma with Extension into Meckel’sCave: Resection using a Retrosigmoid Intradural Suprameatal Approach. J NeurolSurg B Skull Base. 2019 Jun;80(Suppl 3):S300-S301. doi: 10.1055/s-0038-1676996.Epub 2019 Jan 4. PubMed PMID: 31143601; PubMed Central PMCID: PMC6534661.
  • Armstrong FD. Commentary: Implications of health status, health-relatedquality of life, and socio-economic outcomes in survivors of childhood braintumor survivors. Neuro Oncol. 2019 May 11. pii: noz082. doi:10.1093/neuonc/noz082. [Epub ahead of print] PubMed PMID: 31111904; PubMedCentral PMCID: PMC6682210.
  • Sowamber R, Chehade R, Bitar M, Dodds LV, Milea A, Slomovitz B, Shaw PA,George SHL. CCAAT/enhancer binding protein delta (C/EBPδ) demonstrates adichotomous role in tumour initiation and promotion of epithelial carcinoma.EBioMedicine. 2019 Jun;44:261-274. doi: 10.1016/j.ebiom.2019.05.002. Epub 2019May 9. PubMed PMID: 31078521; PubMed Central PMCID: PMC6603855.
  • Otto-Meyer S, Lumibao J, Kim E, Ladomersky E, Zhai L, Lauing KL, ScholtensDM, Penedo F, Amidei C, Lukas RV, Wainwright DA. The interplay amongpsychological distress, the immune system, and brain tumor patient outcomes. CurrOpin Behav Sci. 2019 Aug;28:44-50. doi: 10.1016/j.cobeha.2019.01.009. Epub 2019Feb 26. PubMed PMID: 31049368; PubMed Central PMCID: PMC6487487.
  • Eustace NJ, Anderson JC, Langford CP, Trummell HQ, Hicks PH, Jarboe JS,Mobley JA, Hjelmeland AB, Hackney JR, Pedersen RT, Cosby K, Gillespie GY, BonnerJA, Willey CD. Myristoylated alanine-rich C-kinase substrate effector domainphosphorylation regulates the growth and radiation sensitization of glioblastoma.Int J Oncol. 2019 Jun;54(6):2039-2053. doi: 10.3892/ijo.2019.4766. Epub 2019 Mar. 29. PMID: 30942445; PMCID: PMC6521926
  • Hettiarachchi SD, Graham RM, Mintz KJ, Zhou Y, Vanni S, Peng Z, Leblanc RM.Triple conjugated carbon dots as a nano-drug delivery model for glioblastomabrain tumors. Nanoscale. 2019 Mar 28;11(13):6192-6205. doi: 10.1039/c8nr08970a.PubMed PMID: 30874284; PubMed Central PMCID: PMC6459689.
  • Sansalone L, Veliz EA, Myrthil NG, Stathias V, Walters W, Torrens II, SchürerSC, Vanni S, Leblanc RM, Graham RM. Novel Curcumin Inspired Bis-Chalcone PromotesEndoplasmic Reticulum Stress and Glioblastoma Neurosphere Cell Death. Cancers(Basel). 2019 Mar 13;11(3). pii: E357. doi: 10.3390/cancers11030357. PubMed PMID:30871215; PubMed Central PMCID: PMC6468769.
  •  Richardson AM, McCarthy DJ, Sandhu J, Mayrand R, Guerrero C, Rosenberg C,Gernsback JE, Komotar R, Ivan M. Predictors of Successful Discharge of Patientson Postoperative Day 1 After Craniotomy for Brain Tumor. World Neurosurg. 2019Jun;126:e869-e877. doi: 10.1016/j.wneu.2019.03.004. Epub 2019 Mar 9. PubMed PMID:30862575.
  • Gurbani S, Weinberg B, Cooper L, Mellon E, Schreibmann E, Sheriff S, MaudsleyA, Goryawala M, Shu HK, Shim H. The Brain Imaging Collaboration Suite (BrICS): A Cloud Platform for Integrating Whole-Brain Spectroscopic MRI into the RadiationTherapy Planning Workflow. Tomography. 2019 Mar;5(1):184-191. doi:10.18383/j.tom.2018.00028. PubMed PMID: 30854456; PubMed Central PMCID:PMC6403040
  •  Semonche A, Shah AH, Ivan ME, Komotar RJ. Exosomal MicroRNA in PeripheralSerum as a Noninvasive Diagnostic Biomarker for Glioblastoma. Neurosurgery. 2019Aug 1;85(2):E176-E177. doi: 10.1093/neuros/nyz034. PubMed PMID: 30829375.
  •  Merchant TE, Bendel AE, Sabin ND, Burger PC, Shaw DW, Chang E, Wu S, Zhou T,Eisenstat DD, Foreman NK, Fuller CE, Anderson ET, Hukin J, Lau CC, Pollack IF,Laningham FH, Lustig RH, Armstrong FD, Handler MH, Williams-Hughes C, Kessel S,Kocak M, Ellison DW, Ramaswamy V. Conformal Radiation Therapy for PediatricEpendymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observationfor Completely Resected, Supratentorial Ependymoma. J Clin Oncol. 2019 Apr20;37(12):974-983. doi: 10.1200/JCO.18.01765. Epub 2019 Feb 27. PubMed PMID:30811284.
  • McCarthy D, Starke RM, Sheinberg D, Connolly ES. Treatment Synergy forGlioblastoma Multiforme with SynergySeq. Neurosurgery. 2019 Aug1;85(2):E178-E179. doi: 10.1093/neuros/nyz030. PubMed PMID: 30809656. 
  • Núñez FJ, Mendez FM, Kadiyala P, Alghamri MS, Savelieff MG, Garcia-FabianiMB, Haase S, Koschmann C, Calinescu AA, Kamran N, Saxena M, Patel R, Carney S,Guo MZ, Edwards M, Ljungman M, Qin T, Sartor MA, Tagett R, Venneti S,Brosnan-Cashman J, Meeker A, Gorbunova V, Zhao L, Kremer DM, Zhang L, LyssiotisCA, Jones L, Herting CJ, Ross JL, Hambardzumyan D, Hervey-Jumper S, Figueroa ME,Lowenstein PR, Castro MG. IDH1-R132H acts as a tumor suppressor in glioma viaepigenetic up-regulation of the DNA damage response. Sci Transl Med. 2019 Feb13;11(479). pii: eaaq1427. doi: 10.1126/scitranslmed.aaq1427. PubMed PMID:30760578; PubMed Central PMCID: PMC6400220
  • Shah SS, Rodriguez GA, Musick A, Walters WM, de Cordoba N, Barbarite E,Marlow MM, Marples B, Prince JS, Komotar RJ, Vanni S, Graham RM. TargetingGlioblastoma Stem Cells with 2-Deoxy-D-Glucose (2-DG) PotentiatesRadiation-Induced Unfolded Protein Response (UPR). Cancers (Basel). 2019 Jan31;11(2). pii: E159. doi: 10.3390/cancers11020159. PubMed PMID: 30709011; PubMedCentral PMCID: PMC6406669.
  • Perlow HK, Cassidy V, Farnia B, Kwon D, Awerbuch AW, Ciraula S, Alford S,Griggs J, Quintana JA, Yechieli R, Samuels SE. Impact of Performance Status andComorbidity on Palliative Radiation Treatment Tolerance and End-Of-LifeDecision-Making. Adv Radiat Oncol. 2018 Sep 14;4(1):127-133. doi:10.1016/j.adro.2018.09.002. eCollection 2019 Jan-Mar. PubMed PMID: 30706020;PubMed Central PMCID: PMC6349604.
  • Mintz KJ, Mercado G, Zhou Y, Ji Y, Hettiarachchi SD, Liyanage PY, Pandey RR,Chusuei CC, Dallman J, Leblanc RM. Tryptophan carbon dots and their ability tocross the blood-brain barrier. Colloids Surf B Biointerfaces. 2019 Apr1;176:488-493. doi: 10.1016/j.colsurfb.2019.01.031. Epub 2019 Jan 19. PubMedPMID: 30690384; PubMed Central PMCID: PMC6441370. 
  • Gurbani SS, Sheriff S, Maudsley AA, Shim H, Cooper LAD. Incorporation of aspectral model in a convolutional neural network for accelerated spectralfitting. Magn Reson Med. 2019 May;81(5):3346-3357. doi: 10.1002/mrm.27641. Epub2019 Jan 21. PubMed PMID: 30666698; PubMed Central PMCID: PMC6414236.
  • Khansur E, Shah AH, Lacy K, Komotar RJ. Novel Immunotherapeutics forTreatment of Glioblastoma: The Last Decade of Research. Cancer Invest.2019;37(1):1-7. doi: 10.1080/07357907.2018.1479414. Epub 2019 Jan 11. Review.PubMed PMID: 30632816.
  • Richardson AM, Armstrong VL, Gernsback JE, Gultekin SH, Komotar RJ. CentralNeurocytoma: Rare Presentation in Fourth Ventricle and Review of Literature.World Neurosurg. 2019 Mar;123:357-361. doi: 10.1016/j.wneu.2018.12.021. Epub 2018Dec 19. Review. PubMed PMID: 30579012.
  • Verma G, Chawla S, Mohan S, Wang S, Nasrallah M, Sheriff S, Desai A, Brem S,O’Rourke DM, Wolf RL, Maudsley AA, Poptani H. Three-dimensional echo planarspectroscopic imaging for differentiation of true progression frompseudoprogression in patients with glioblastoma. NMR Biomed. 2019Feb;32(2):e4042. doi: 10.1002/nbm.4042. Epub 2018 Dec 17. PubMed PMID: 30556932;PubMed Central PMCID: PMC6519064.
  • Liyanage PY, Graham RM, Pandey RR, Chusuei CC, Mintz KJ, Zhou Y, Harper JK,Wu W, Wikramanayake AH, Vanni S, Leblanc RM. Carbon Nitride Dots: A SelectiveBioimaging Nanomaterial. Bioconjug Chem. 2019 Jan 16;30(1):111-123. doi:10.1021/acs.bioconjchem.8b00784. Epub 2018 Dec 21. PubMed PMID: 30525487.
  • Eichberg DG, Achua JK, Locatelli E, Shah AH, Komotar RJ, Ghods AJ. PrimaryDiffuse Leptomeningeal Melanomatosis: Case Report and Review of the Literature.World Neurosurg. 2019 Feb;122:648-655. doi: 10.1016/j.wneu.2018.11.163. Epub 2018Nov 26. Review. PubMed PMID: 30496931.
  • Rodriguez-Blanco J, Li B, Long J, Shen C, Yang F, Orton D, Collins S,Kasahara N, Ayad NG, McCrea HJ, Roussel MF, Weiss WA, Capobianco AJ, Robbins DJ.A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistantMetastatic Medulloblastoma. Clin Cancer Res. 2019 Feb 15;25(4):1379-1388. doi:10.1158/1078-0432.CCR-18-1319. Epub 2018 Nov 28. PubMed PMID: 30487124. 
  • Johnson PB, Monterroso MI, Yang F, Bossart E, Keyvanloo A, Mellon EA.Clinical Evaluation of Shot-Within-Shot Optimization for Gamma Knife RadiosurgeryPlanning and Delivery. World Neurosurg. 2019 Mar;123:e218-e227. doi:10.1016/j.wneu.2018.11.140. Epub 2018 Nov 24. PubMed PMID: 30481630.
  • Shah AH, Kuchakulla M, Ibrahim GM, Dadheech E, Komotar RJ, Gultekin SH, IvanFraction and Radiation Necrosis in Recurrent Intracranial Tumors. WorldNeurosurg. 2019 Jan;121:e836-e842. doi: 10.1016/j.wneu.2018.09.233. Epub 2018 Oct 9. 
  • Wei J, Marisetty A, Schrand B, Gabrusiewicz K, Hashimoto Y, Ott M, Grami Z,Kong LY, Ling X, Caruso H, Zhou S, Wang YA, Fuller GN, Huse J, Gilboa E, Kang N,Huang X, Verhaak R, Li S, Heimberger AB. Osteopontin mediatesglioblastoma-associated macrophage infiltration and is a potential therapeutictarget. J Clin Invest. 2019 Jan 2;129(1):137-149. doi: 10.1172/JCI121266. Epub2018 Nov 19. PubMed PMID: 30307407; PubMed Central PMCID: PMC6307970.
  • Eichberg DG, Buttrick SS, Sharaf JM, Snelling BM, Shah AH, Ivan ME, Komotar Experience and Review of the Literature. Oper Neurosurg (Hagerstown). 2019 May1;16(5):571-579. doi: 10.1093/ons/opy249. PubMed PMID: 30202893.
  • Shah AH, Burks JD, Buttrick SS, Debs L, Ivan ME, Komotar RJ. LaserInterstitial Thermal Therapy as a Primary Treatment for Deep InaccessibleGliomas. Neurosurgery. 2019 Mar 1;84(3):768-777. doi: 10.1093/neuros/nyy238.PubMed PMID: 29873756.
  • Eichberg DG, Buttrick S, White K, Gultekin SH, Komotar RJ. PAX8 ExpressionVariability in Cerebellar Hemangioblastoma: Case Series and Review of theLiterature. Appl Immunohistochem Mol Morphol. 2019 Jul;27(6):477-481. doi:10.1097/PAI.0000000000000649. PubMed PMID: 29629948.
Mayo Clinic, Florida 
  • Yang Z, Shi J, Xie J, Wang Y, Sun J, Liu T, Zhao Y, Zhao X, Wang X, Ma Y,Malkoc V, Chiang C, Deng W, Chen Y, Fu Y, Kwak KJ, Fan Y, Kang C, Yin C, Rhee J,Bertani P, Otero J, Lu W, Yun K, Lee AS, Jiang W, Teng L, Kim BYS, Lee LJ.Large-scale generation of functional mRNA-encapsulating exosomes via cellularnanoporation. Nat Biomed Eng. 2019 Dec 16. doi: 10.1038/s41551-019-0485-1. [Epubahead of print] PubMed PMID: 31844155.
  • Lu VM, Akinduro OO, Daniels DJ. H3K27M mutation in adult cerebellarglioblastoma. J Clin Neurosci. 2019 Dec 13. pii: S0967-5868(19)30709-X. doi:10.1016/j.jocn.2019.11.016. [Epub ahead of print] PubMed PMID: 31843430.
  • Goldstein ED, Kyper CM, Siegel JL. Diffuse Midline Glioma H3 K27M-MutantManifested as Progressive Paraplegia. Neurohospitalist. 2020 Jan;10(1):73-74.doi: 10.1177/1941874419847347. Epub 2019 May 7. PubMed PMID: 31839872; PubMedCentral PMCID: PMC6900658.
  • Mackintosh C, Tewari A, Siegel J, Wang RD, Freeman W. Postoperative EuglycemicDiabetic Ketoacidosis and Encephalopathy Related to SGLT-2 Inhibitors: A CaseReport and Discussion of Diabetes Treatment and “Sweet Pee Encephalopathy” inPerioperative Hospital Management. Neurohospitalist. 2020 Jan;10(1):51-54. doi:10.1177/1941874419835035. Epub 2019 Mar 7. PubMed PMID: 31839866; PubMed CentralPMCID: PMC6900651.
  • Singh R, Lehrer EJ, Ko S, Peterson J, Lou Y, Porter AB, Kotecha R, Brown PD,Zaorsky NG, Trifiletti DM. Brain metastases from non-small cell lung cancer with EGFR or ALK mutations: A systematic review and meta-analysis of multidisciplinaryapproaches. Radiother Oncol. 2019 Dec 5;144:165-179. doi:10.1016/j.radonc.2019.11.010. [Epub ahead of print] Review. PubMed PMID:31812932.
  • Murphy ES, Parsai S, Kano H, Sheehan JP, Martinez-Alvarez R, Martinez-MorenoN, Kondziolka D, Simonova G, Liscak R, Mathieu D, Lee CC, Yang HC, Lee JY,McShane BJ, Fang F, Trifiletti DM, Sharma M, Barnett GH. Outcomes of stereotacticradiosurgery for pilocytic astrocytoma: an international multiinstitutionalstudy. J Neurosurg. 2019 Nov 29:1-9. doi: 10.3171/2019.9.JNS191335. [Epub aheadof print] PubMed PMID: 31783364.
  • Bovi JA, Pugh SL, Sabsevitz D, Robinson CG, Paulson E, Mehta MP, Gondi V,Kundapur V, Shahin MS, Chao ST, Machtay M, DeNittis AS, Laack NN, Greenspoon JN,Moore KN, Huang J, Dominello MM, Kachnic LA. Pretreatment Volume ofMRI-Determined White Matter Injury Predicts Neurocognitive Decline AfterHippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases:Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933. AdvRadiat Oncol. 2019 Jul 16;4(4):579-586. doi: 10.1016/j.adro.2019.07.006. eCollection 2019 Oct-Dec. PubMed PMID: 31673651; PubMed Central PMCID:PMC6817553.
  • Tawk RG, Akinduro OO, Grewal SS, Brasiliense L, Grand W, Grotenhuis A.Endoscopic Transforaminal Transchoroidal Approach to the Third Ventricle forCystic and Solid Tumors. World Neurosurg. 2019 Oct 24. pii:S1878-8750(19)32718-4. doi: 10.1016/j.wneu.2019.10.099. [Epub ahead of print]PubMed PMID: 31669244.
  • Trifiletti DM, Ballman KV, Brown PD, Anderson SK, Carrero XW, Cerhan JH,Whitton AC, Greenspoon J, Parney IF, Laack NN, Ashman JB, Bahary JP, HadjipanayisCG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC,Galanis E, Roberge D. Optimizing Whole Brain Radiation Therapy Dose andFractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C[Alliance]/CEC.3). Int J Radiat Oncol Biol Phys. 2019 Oct 22. pii:S0360-3016(19)33906-9. doi: 10.1016/j.ijrobp.2019.10.024. [Epub ahead of print]PubMed PMID: 31654784.
  • Leon J, Lehrer EJ, Peterson J, Vallow L, Ruiz-Garcia H, Hadley A, Herchko S,Lundy L, Chaichana K, Vibhute P, Sheehan JP, Trifiletti DM. Observation orstereotactic radiosurgery for newly diagnosed vestibular schwannomas: Asystematic review and meta-analysis. J Radiosurg SBRT. 2019;6(2):91-100. PubMedPMID: 31641546; PubMed Central PMCID: PMC6774488.
  • Karlsson J, Rui Y, Kozielski KL, Placone AL, Choi O, Tzeng SY, Kim J, KeyesJJ, Bogorad MI, Gabrielson K, Guerrero-Cazares H, Quiñones-Hinojosa A, SearsonPC, Green JJ. Engineered nanoparticles for systemic siRNA delivery to malignantbrain tumours. Nanoscale. 2019 Nov 14;11(42):20045-20057. doi:10.1039/c9nr04795f. Epub 2019 Oct 15. PubMed PMID: 31612183.
  • Kaleem T, Malouff TD, Stross WC, Waddle MR, Miller DH, Seymour AL, ZaorskyNG, Miller RC, Trifiletti DM, Vallow L. Google Search Trends in Oncology and the Impact of Celebrity Cancer Awareness. Cureus. 2019 Aug 10;11(8):e5360. doi:10.7759/cureus.5360. PubMed PMID: 31608195; PubMed Central PMCID: PMC6783227.
  • Feyissa AM. Brivaracetam in the treatment of epilepsy: a review of clinicaltrial data. Neuropsychiatr Dis Treat. 2019 Sep 9;15:2587-2600. doi:10.2147/NDT.S143548. eCollection 2019. PubMed PMID: 31571877; PubMed CentralPMCID: PMC6750854.
  • Malouff TD, Peterson JL, Mahajan A, Trifiletti DM. Carbon ion radiotherapy inthe treatment of gliomas: a review. J Neurooncol. 2019 Nov;145(2):191-199. doi:10.1007/s11060-019-03303-y. Epub 2019 Sep 30. Review. PubMed PMID: 31571113.
  • Alonso CE, Bunevicius A, Trifiletti DM, Larner J, Lee CC, Pai FY, Liscak R,Kosak M, Kano H, Sisterson ND, Mathieu D, Lunsford LD, Sheehan JP. Safety andefficacy of repeat radiosurgery for acromegaly: an InternationalMulti-Institutional Study. J Neurooncol. 2019 Nov;145(2):301-307. doi:10.1007/s11060-019-03296-8. Epub 2019 Sep 20. PubMed PMID: 31541405
  • Lu VM, George ND, Brown DA, Akinduro OO, Raghunathan A, Jentoft M,Quinones-Hinojosa A, Chaichana KL. Confirming Diagnosis and Effective Treatmentfor Rare Epithelioid Glioblastoma Variant: An Integrated Survival Analysis of theLiterature. World Neurosurg. 2019 Nov;131:243-251.e2. doi:10.1016/j.wneu.2019.08.007. Epub 2019 Aug 9. Review. PubMed PMID: 31404694.
  • Cerhan JH, Anderson SK, Butts AM, Porter AB, Jaeckle K, Galanis E, Brown PD.Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology. Neurooncol Pract.2019 Jul;6(4):283-288. doi: 10.1093/nop/npy048. Epub 2018 Nov 24. PubMed PMID:31386061; PubMed Central PMCID: PMC6660817.
  • Shah SR, Quinones-Hinojosa A, Xia S. Advances in Brain Cancer: Creating Monoallelic Single Point Mutation in IDH1 by Single Base Editing. J Oncol ResTher. 2019;5(5). pii: 166. Epub 2018 Oct 3. PubMed PMID: 31328182; PubMed CentralPMCID: PMC6641564.
  • Leon J, Trifiletti DM, Waddle MR, Vallow L, Ko S, May B, Tzou K, Ruiz-GarciaH, Lundy L, Chaichana K, Vibhute P, Peterson JL. Trends in the initial managementof vestibular schwannoma in the United States. J Clin Neurosci. 2019Oct;68:174-178. doi: 10.1016/j.jocn.2019.07.002. Epub 2019 Jul 16. PubMed PMID:31324471.
  • Juarez-Chambi RM, Kut C, Rico-Jimenez JJ, Chaichana KL, Xi J, Campos-DelgadoDU, Rodriguez FJ, Quinones-Hinojosa A, Li X, Jo JA. AI-Assisted In Situ Detectionof Human Glioma Infiltration Using a Novel Computational Method for OpticalCoherence Tomography. Clin Cancer Res. 2019 Nov 1;25(21):6329-6338. doi:10.1158/1078-0432.CCR-19-0854. Epub 2019 Jul 17. PubMed PMID: 31315883; PubMedCentral PMCID: PMC6825537.
  • Galanis E, Anderson SK, Twohy EL, Carrero XW, Dixon JG, Tran DD, JeyapalanSA, Anderson DM, Kaufmann TJ, Feathers RW, Giannini C, Buckner JC, AnastasiadisPZ, Schiff D. A phase 1 and randomized, placebo-controlled phase 2 trial ofbevacizumab plus dasatinib in patients with recurrent glioblastoma:Alliance/North Central Cancer Treatment Group N0872. Cancer. 2019 Nov1;125(21):3790-3800. doi: 10.1002/cncr.32340. Epub 2019 Jul 10. PubMed PMID:31290996; PubMed Central PMCID: PMC6788934
  • ReFaey K, Chaichana KL, Feyissa AM, Vivas-Buitrago T, Brinkmann BH,Middlebrooks EH, McKay JH, Lankford DJ, Tripathi S, Bojaxhi E, Roth GE, Tatum WO,Quiñones-Hinojosa A. A 360° electronic device for recording high-resolutionintraoperative electrocorticography of the brain during awake craniotomy. JNeurosurg. 2019 Jul 5:1-8. doi: 10.3171/2019.4.JNS19261. [Epub ahead of print]PubMed PMID: 31277069.
  • Picariello HS, Kenchappa RS, Rai V, Crish JF, Dovas A, Pogoda K, McMahon M,Bell ES, Chandrasekharan U, Luu A, West R, Lammerding J, Canoll P, Odde DJ,Janmey PA, Egelhoff T, Rosenfeld SS. Myosin IIA suppresses glioblastomadevelopment in a mechanically sensitive manner. Proc Natl Acad Sci U S A. 2019Jul 30;116(31):15550-15559. doi: 10.1073/pnas.1902847116. Epub 2019 Jun 24.PubMed PMID: 31235578; PubMed Central PMCID: PMC6681735.
  • Cantrell JN, Waddle MR, Rotman M, Peterson JL, Ruiz-Garcia H, Heckman MG,Quiñones-Hinojosa A, Rosenfeld SS, Brown PD, Trifiletti DM. Progress TowardLong-Term Survivors of Glioblastoma. Mayo Clin Proc. 2019 Jul;94(7):1278-1286.doi: 10.1016/j.mayocp.2018.11.031. Epub 2019 Jun 20. PubMed PMID: 31230743.
  • Lu VM, Wahood W, Akinduro OO, Parney IF, Quinones-Hinojosa A, Chaichana KL.Four Independent Predictors of Postoperative Seizures After Meningioma Surgery: AMeta-Analysis. World Neurosurg. 2019 Oct;130:537-545.e3. doi:10.1016/j.wneu.2019.06.063. Epub 2019 Jun 19. Review. PubMed PMID: 31226449.
  • Tatum WO, Feyissa AM, ReFaey K, Grewal SS, Alvi MA, Castro-Apolo R, Roth G,Segura-Duran I, Mahato D, Ruiz-Garcia H, Pamias-Portalatin E, Yelvington K,Chaichana K, Bechtle P, Quinones-Hinojosa A. Periodic focal epileptiformdischarges. Clin Neurophysiol. 2019 Aug;130(8):1320-1328. doi:10.1016/j.clinph.2019.04.718. Epub 2019 May 31. PubMed PMID: 31185363.
  • Akinduro OO, Lu VM, Izzo A, De Biase G, Vilanilam G, Van Gompel JJ, Bernet V,Donaldson A, Olomu O, Meyer FB, Quinones-Hinojosa A, Chaichana KL. Radiographicand Hormonal Regression in Prolactinomas: An Analysis of Treatment Failure. WorldNeurosurg. 2019 Sep;129:e686-e694. doi: 10.1016/j.wneu.2019.05.249. Epub 2019 Jun 7. PubMed PMID: 31181361.
  • Gruenbaum BF, Gruenbaum SE. Neurophysiological monitoring duringneurosurgery: anesthetic considerations based on outcome evidence. Curr OpinAnaesthesiol. 2019 Oct;32(5):580-584. doi: 10.1097/ACO.0000000000000753. PubMedPMID: 31145200
  • Feyissa AM, Worrell GA, Tatum WO, Chaichana KL, Jentoft ME, Guerrero CazaresH, Ertekin-Taner N, Rosenfeld SS, ReFaey K, Quinones-Hinojosa A. Potentialinfluence of IDH1 mutation and MGMT gene promoter methylation on glioma-relatedpreoperative seizures and postoperative seizure control. Seizure. 2019Jul;69:283-289. doi: 10.1016/j.seizure.2019.05.018. Epub 2019 May 20. PubMedPMID: 31141785.
  • Aulakh S, DeDeo MR, Free J, Rosenfeld SS, Quinones-Hinojosa A, Paulus A,Manna A, Manochakian R, Chanan-Khan AA, Ailawadhi S. Survival trends inglioblastoma and association with treating facility volume. J Clin Neurosci. 2019Oct;68:271-274. doi: 10.1016/j.jocn.2019.04.028. Epub 2019 May 24. PubMed PMID:31133366.
  • Zarco N, Norton E, Quiñones-Hinojosa A, Guerrero-Cázares H. Overlappingmigratory mechanisms between neural progenitor cells and brain tumor stem cells.Cell Mol Life Sci. 2019 Sep;76(18):3553-3570. doi: 10.1007/s00018-019-03149-7.Epub 2019 May 17. Review. PubMed PMID: 31101934
  • Waddle MR, Oudenhoven MD, Farin CV, Deal AM, Hoffman R, Yang H, Peterson J,Armstrong TS, Ewend MG, Wu J. Impacts of Surgery on Symptom Burden and Quality ofLife in Pituitary Tumor Patients in the Subacute Post-operative Period. FrontOncol. 2019 Apr 23;9:299. doi: 10.3389/fonc.2019.00299. eCollection 2019. PubMedPMID: 31065545
  • Lu VM, Alvi MA, Bydon M, Quinones-Hinojosa A, Chaichana KL. Impact of 1p/19q codeletion status on extent of resection in WHO grade II glioma: Insights from a national cancer registry. Clin Neurol Neurosurg. 2019 Jul;182:32-36. doi:10.1016/j.clineuro.2019.04.027. Epub 2019 Apr 30. PubMed PMID: 31063969.
  • Kozielski KL, Ruiz-Valls A, Tzeng SY, Guerrero-Cázares H, Rui Y, Li Y,Vaughan HJ, Gionet-Gonzales M, Vantucci C, Kim J, Schiapparelli P, Al-KharbooshR, Quiñones-Hinojosa A, Green JJ. Cancer-selective nanoparticles forcombinatorial siRNA delivery to primary human GBM in vitro and in vivo.Biomaterials. 2019 Jul;209:79-87. doi: 10.1016/j.biomaterials.2019.04.020. Epub2019 Apr 12. PubMed PMID: 31026613.
  • Akinduro OO, Lundy LB, Quinones-Hinojosa A, Lu VM, Trifiletti DM, Gupta V,Wharen RE. Outcomes of large vestibular schwannomas following subtotal resection:early post-operative volume regression and facial nerve function. J Neurooncol.2019 Jun;143(2):281-288. doi: 10.1007/s11060-019-03157-4. Epub 2019 Apr 15.PubMed PMID: 30989621.
  • Akinduro OO, Izzo A, Lu VM, Ricciardi L, Trifiletti D, Peterson JL, Bernet V,Donaldson A, Eggenberger E, Olomu O, Reimer R, Wharen R, Quinones-Hinojosa A,Chaichana KL. Endocrine and Visual Outcomes Following Gross Total Resection andSubtotal Resection of Adult Craniopharyngioma: Systematic Review andMeta-Analysis. World Neurosurg. 2019 Jul;127:e656-e668. doi:10.1016/j.wneu.2019.03.239. Epub 2019 Apr 1. PubMed PMID: 30947004.
  • Lu VM, Goyal A, Graffeo CS, Perry A, Burns TC, Parney IF, Quinones-HinojosaA, Chaichana KL. Survival Benefit of Maximal Resection for GlioblastomaReoperation in the Temozolomide Era: A Meta-Analysis. World Neurosurg. 2019Jul;127:31-37. doi: 10.1016/j.wneu.2019.03.250. Epub 2019 Apr 1. Review. PubMedPMID: 30947000.
  • Lu VM, Kerezoudis P, Brown DA, Burns TC, Quinones-Hinojosa A, Chaichana KL.Hypofractionated versus standard radiation therapy in combination withtemozolomide for glioblastoma in the elderly: a meta-analysis. J Neurooncol. 2019Jun;143(2):177-185. doi: 10.1007/s11060-019-03155-6. Epub 2019 Mar 27. Review.PubMed PMID: 30919157.
  • Gassie K, Alvarado-Estrada K, Bechtle P, Chaichana KL. Surgical Management ofDeep-Seated Metastatic Brain Tumors Using Minimally Invasive Approaches. J NeurolSurg A Cent Eur Neurosurg. 2019 May;80(3):198-204. doi: 10.1055/s-0038-1676575. Epub 2019 Mar 20. PubMed PMID: 30895569.
  • Agely A, Okromelidze L, Vilanilam GK, Chaichana KL, Middlebrooks EH, Gupta V.Ectopic pituitary adenomas: common presentations of a rare entity. Pituitary.2019 Aug;22(4):339-343. doi: 10.1007/s11102-019-00954-y. PubMed PMID: 30895500.
  • Chen Y, Liu X, Yuan H, Yang Z, von Roemeling CA, Qie Y, Zhao H, Wang Y, JiangW, Kim BYS. Therapeutic Remodeling of the Tumor Microenvironment EnhancesNanoparticle Delivery. Adv Sci (Weinh). 2019 Jan 22;6(5):1802070. doi:10.1002/advs.201802070. eCollection 2019 Mar 6. PubMed PMID: 30886813
  • Mampre D, Ehresman J, Alvarado-Estrada K, Wijesekera O, Sarabia-Estrada R,Quinones-Hinojosa A, Chaichana KL. Propensity for different vasculardistributions and cerebral edema of intraparenchymal brain metastases fromdifferent primary cancers. J Neurooncol. 2019 May;143(1):115-122. doi:10.1007/s11060-019-03142-x. Epub 2019 Mar 5. PubMed PMID: 30835021.
  • Xin Y, Gao X, Liu L, Ge WP, Jain MK, Cai H. Evaluation ofL-1-[(18)F]Fluoroethyl-Tryptophan for PET Imaging of Cancer. Mol Imaging Biol.2019 Dec;21(6):1138-1146. doi: 10.1007/s11307-019-01327-4. PubMed PMID: 30815792
  • Shah SR, Kim J, Schiapparelli P, Vazquez-Ramos CA, Martinez-Gutierrez JC,Ruiz-Valls A, Inman K, Shamul JG, Green JJ, Quinones-Hinojosa A.Verteporfin-Loaded Polymeric Microparticles for Intratumoral Treatment of BrainCancer. Mol Pharm. 2019 Apr 1;16(4):1433-1443. doi:10.1021/acs.molpharmaceut.8b00959. Epub 2019 Mar 11. PubMed PMID: 30803231.
  • Ehresman JS, Garzon-Muvdi T, Rogers D, Lim M, Gallia GL, Weingart J, Brem H,Bettegowda C, Chaichana KL. Risk of Developing Postoperative Deficits Based onTumor Location after Surgical Resection of an Intracranial Meningioma. J NeurolSurg B Skull Base. 2019 Feb;80(1):59-66. doi: 10.1055/s-0038-1667066. Epub 2018Jul 17. PubMed PMID: 30733902; PubMed Central PMCID: PMC6365240. 
  • Cannon MJ, Block MS, Morehead LC, Knutson KL. The evolving clinical landscapefor dendritic cell vaccines and cancer immunotherapy. Immunotherapy. 2019Feb;11(2):75-79. doi: 10.2217/imt-2018-0129. PubMed PMID: 30730268.
  • Plummer S, Wallace S, Ball G, Lloyd R, Schiapparelli P, Quiñones-Hinojosa A,Hartung T, Pamies D. A Human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine. Sci Rep. 2019 Feb5;9(1):1407. doi: 10.1038/s41598-018-38130-0. PubMed PMID: 30723234; PubMedCentral PMCID: PMC6363784.
  • Fega KR, Fletcher GP, Waddle MR, Peterson JL, Ashman JB, Barrs DM, Bendok BR,Patel NP, Porter AB, Vora SA. Analysis of MRI Volumetric Changes AfterHypofractionated Stereotactic Radiation Therapy for Benign IntracranialNeoplasms. Adv Radiat Oncol. 2018 Aug 23;4(1):43-49. doi:10.1016/j.adro.2018.08.013. eCollection 2019 Jan-Mar. PubMed PMID: 30706009;PubMed Central PMCID: PMC6349623.
  • Lu VM, Goyal A, Quinones-Hinojosa A, Chaichana KL. Updated incidence ofneurological deficits following insular glioma resection: A systematic review andmeta-analysis. Clin Neurol Neurosurg. 2019 Feb;177:20-26. doi:10.1016/j.clineuro.2018.12.013. Epub 2018 Dec 17. Review. PubMed PMID: 30580067.
  • Lu VM, Goyal A, Lee A, Jentoft M, Quinones-Hinojosa A, Chaichana KL. Theprognostic significance of TERT promoter mutations in meningioma: a systematicreview and meta-analysis. J Neurooncol. 2019 Mar;142(1):1-10. doi:10.1007/s11060-018-03067-x. Epub 2018 Dec 1. PubMed PMID: 30506498.
  • Dhamija R, Wood CP, Porter AB, Hu LS, Weindling SM, Hoxworth JM. UpdatedImaging Features of Dysplastic Cerebellar Gangliocytoma. J Comput Assist Tomogr.2019 Mar/Apr;43(2):277-281. doi: 10.1097/RCT.0000000000000814. PubMed PMID:30407243.
  • Lehrer EJ, Peterson JL, Zaorsky NG, Brown PD, Sahgal A, Chiang VL, Chao ST,Sheehan JP, Trifiletti DM. Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials. Int JRadiat Oncol Biol Phys. 2019 Mar 1;103(3):618-630. doi:10.1016/j.ijrobp.2018.10.038. Epub 2018 Nov 2. PubMed PMID: 30395902.
  • Al-Kharboosh R, Lara-Velazquez M, Prieto L, Sarabia-Estrada R,Quiñones-Hinojosa A. The Study of Brain Tumor Stem Cell Invasion. Methods MolBiol. 2019;1869:105-116. doi: 10.1007/978-1-4939-8805-1_10. PubMed PMID:30324518; PubMed Central PMCID: PMC6379892.
  • Lara-Velazquez M, Al-Kharboosh R, Prieto L, Schiapparelli P,Quiñones-Hinojosa A. The Study of Brain Tumor Stem Cell Migration. Methods MolBiol. 2019;1869:93-104. doi: 10.1007/978-1-4939-8805-1_9. PubMed PMID: 30324517;PubMed Central PMCID: PMC6379916.
  • Kinali B, Senoglu M, Karadag FK, Karadag A, Middlebrooks EH, Oksuz P, SandalE, Turk C, Diniz G. Hypoxia-Inducible Factor 1α and AT-Rich InteractiveDomain-Containing Protein 1A Expression in Pituitary Adenomas: Association withPathological, Clinical, and Radiological Features. World Neurosurg. 2019Jan;121:e716-e722. doi: 10.1016/j.wneu.2018.09.196. Epub 2018 Oct 5. PubMed PMID:30292665.
  • Lehrer EJ, Peterson J, Brown PD, Sheehan JP, Quiñones-Hinojosa A, Zaorsky NG,Trifiletti DM. Treatment of brain metastases with stereotactic radiosurgery andimmune checkpoint inhibitors: An international meta-analysis of individualpatient data. Radiother Oncol. 2019 Jan;130:104-112. doi:10.1016/j.radonc.2018.08.025. Epub 2018 Sep 18. PubMed PMID: 30241791.
Moffitt Cancer Center
  • Haider AS, van den Bent M, Wen PY, Vogelbaum MA, Chang S, Canoll PD, HorbinskiCM, Huse JT. Towards a standard pathological and molecular characterization ofrecurrent glioma in adults: a RANO effort. Neuro Oncol. 2019 Dec 17. pii: noz233.doi: 10.1093/neuonc/noz233. [Epub ahead of print] PubMed PMID: 31844891.
  • Drilon A, Siena S, Dziadziuszko R, Barlesi F, Krebs MG, Shaw AT, de Braud F,Rolfo C, Ahn MJ, Wolf J, Seto T, Cho BC, Patel MR, Chiu CH, John T, Goto K,Karapetis CS, Arkenau HT, Kim SW, Ohe Y, Li YC, Chae YK, Chung CH, Otterson GA,Murakami H, Lin CC, Tan DSW, Prenen H, Riehl T, Chow-Maneval E, Simmons B, Cui N,Johnson A, Eng S, Wilson TR, Doebele RC; trial investigators. Entrectinib in ROS1fusion-positive non-small-cell lung cancer: integrated analysis of three phase1-2 trials. Lancet Oncol. 2019 Dec 11. pii: S1470-2045(19)30690-4. doi:10.1016/S1470-2045(19)30690-4. [Epub ahead of print] PubMed PMID: 31838015.
  • Rogers CL, Won M, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, GalvinJ, Fogh SE, Youssef E, Deb N, Kwok Y, Robinson CG, Shu HK, Fisher BJ,Panet-Raymond V, McMillan WG, de Groot JF, Zhang P, Mehta MP. High-riskmeningioma: Initial outcomes from NRG Oncology/RTOG 0539. Int J Radiat Oncol BiolPhys. 2019 Nov 28. pii: S0360-3016(19)34067-2. doi: 10.1016/j.ijrobp.2019.11.028.[Epub ahead of print] PubMed PMID: 31786276.
  • Piña Y, Fusco MJ, Macaulay RJ, Walko CM, Peguero E, Evernden BR, Smalley KS,Forsyth P. Using personalized medicine in gliomas: a genomic approach todiagnosis and overcoming treatment resistance in a case with pleomorphicxanthoastrocytoma. J Neurol. 2019 Nov 21. doi: 10.1007/s00415-019-09575-8. [Epubahead of print] PubMed PMID: 31748891.
  • Chobrutskiy BI, Yeagley M, Tipping P, Zaman S, Diviney A, Patel DN, FalasiriS, Uversky VN, Blanck G. Chemical complementarity between immune receptor CDR3sand IDH1 mutants correlates with increased survival for lower grade glioma.Oncogene. 2019 Nov 18. doi: 10.1038/s41388-019-1101-2. [Epub ahead of print]PubMed PMID: 31740784.
  • Owonikoko TK, Niu H, Nackaerts K, Csoszi T, Ostoros G, Mark Z, Baik C, Joy AA,Chouaid C, Jaime JC, Kolek V, Majem M, Roubec J, Santos ES, Chiang AC, SperanzaG, Belani CP, Chiappori A, Patel MR, Czebe K, Byers L, Bahamon B, Li C,Sheldon-Waniga E, Kong EF, Williams M, Badola S, Shin H, Bedford L, Ecsedy JA,Bryant M, Jones S, Simmons J, Leonard EJ, Ullmann CD, Spigel DR; C14018 studyinvestigators. Randomized Phase II Study of Paclitaxel plus Alisertib versusPaclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses. J Thorac Oncol. 2019 Oct 23. pii: S1556-0864(19)33572-5. doi:10.1016/j.jtho.2019.10.013. [Epub ahead of print] PubMed PMID: 31655296.
  • Ranjbar S, Singleton KW, Jackson PR, Rickertsen CR, Whitmire SA, Clark-SwansonKR, Mitchell JR, Swanson KR, Hu LS. A Deep Convolutional Neural Network forAnnotation of Magnetic Resonance Imaging Sequence Type. J Digit Imaging. 2019 Oct25. doi: 10.1007/s10278-019-00282-4. [Epub ahead of print] PubMed PMID: 31654174.
  • Tan Y, Mu W, Wang XC, Yang GQ, Gillies RJ, Zhang H. Improving survivalprediction of high-grade glioma via machine learning techniques based on MRIradiomic, genetic and clinical risk factors. Eur J Radiol. 2019 Nov;120:108609.doi: 10.1016/j.ejrad.2019.07.010. Epub 2019 Jul 13. PubMed PMID: 31606714.
  • Peereboom DM, Alban TJ, Grabowski MM, Alvarado AG, Otvos B, Bayik D, RoversiG, McGraw M, Huang P, Mohammadi AM, Kornblum HI, Radivoyevitch T, Ahluwalia MS,Vogelbaum MA, Lathia JD. Metronomic capecitabine as an immune modulator inglioblastoma patients reduces myeloid-derived suppressor cells. JCI Insight. 2019Nov 14;4(22). pii: 130748. doi: 10.1172/jci.insight.130748. PubMed PMID:31600167.
  • Wu Q, Berglund AE, Wang D, MacAulay RJ, Mulé JJ, Etame AB. Paradoxicalepigenetic regulation of XAF1 mediates plasticity towards adaptive resistanceevolution in MGMT-methylated glioblastoma. Sci Rep. 2019 Oct 1;9(1):14072. doi:10.1038/s41598-019-50489-2. PubMed PMID: 31575897; PubMed Central PMCID:PMC6773736.
  • Cote DJ, Rosner BA, Smith-Warner SA, Egan KM, Stampfer MJ. Statin use,hyperlipidemia, and risk of glioma. Eur J Epidemiol. 2019 Nov;34(11):997-1011.doi: 10.1007/s10654-019-00565-8. Epub 2019 Sep 26. PubMed PMID: 31559554.
  • Tom MC, Park DYJ, Yang K, Leyrer CM, Wei W, Jia X, Varra V, Yu JS, Chao ST,Balagamwala EH, Suh JH, Vogelbaum MA, Barnett GH, Prayson RA, Stevens GHJ,Peereboom DM, Ahluwalia MS, Murphy ES. Malignant Transformation of MolecularlyClassified Adult Low-Grade Glioma. Int J Radiat Oncol Biol Phys. 2019 Dec1;105(5):1106-1112. doi: 10.1016/j.ijrobp.2019.08.025. Epub 2019 Aug 25. PubMedPMID: 31461674.
  • Figura NB, Potluri TK, Mohammadi H, Oliver DE, Arrington JA, Robinson TJ,Etame AB, Tran ND, Liu JK, Soliman H, Forsyth PA, Sahebjam S, Yu HM, Han HS,Ahmed KA. CDK 4/6 inhibitors and stereotactic radiation in the management ofhormone receptor positive breast cancer brain metastases. J Neurooncol. 2019Sep;144(3):583-589. doi: 10.1007/s11060-019-03260-6. Epub 2019 Aug 9. PubMedPMID: 31399935.
  • Creed JH, Peeri NC, Anic GM, Thompson RC, Olson JJ, LaRocca RV, Chowdhary SA,Brockman JD, Gerke TA, Nabors LB, Egan KM. Methylmercury exposure, geneticvariation in metabolic enzymes, and the risk of glioma. Sci Rep. 2019 Jul26;9(1):10861. doi: 10.1038/s41598-019-47284-4. PubMed PMID: 31350461; PubMedCentral PMCID: PMC6659774.
  • Johnston SK, Whitmire P, Massey SC, Kumthekar P, Porter AB, Raghunand N,Gonzalez-Cuyar LF, Mrugala MM, Hawkins-Daarud A, Jackson PR, Hu LS, Sarkaria JN,Wang L, Gatenby RA, Egan KM, Canoll P, Swanson KR; ENDURES consortium.Environmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) ofGlioblastoma: A Multidisciplinary Team-based, Multifactorial Analytical Approach.Am J Clin Oncol. 2019 Aug;42(8):655-661. doi: 10.1097/COC.0000000000000564.PubMed PMID: 31343422.
  • Gaw N, Hawkins-Daarud A, Hu LS, Yoon H, Wang L, Xu Y, Jackson PR, SingletonKW, Baxter LC, Eschbacher J, Gonzales A, Nespodzany A, Smith K, Nakaji P,Mitchell JR, Wu T, Swanson KR, Li J. Integration of machine learning andmechanistic models accurately predicts variation in cell density of glioblastoma using multiparametric MRI. Sci Rep. 2019 Jul 11;9(1):10063. doi:10.1038/s41598-019-46296-4. PubMed PMID: 31296889; PubMed Central PMCID:PMC6624304.
  • Lassman AB, Aldape KD, Ansell PJ, Bain E, Curran WJ, Eoli M, French PJ,Kinoshita M, Looman J, Mehta M, Muragaki Y, Narita Y, Ocampo C, Roberts-Rapp L,Song M, Vogelbaum MA, Walenkamp AME, Wang TJC, Zhang P, van den Bent MJ.Epidermal growth factor receptor (EGFR) amplification rates observed in screeningpatients for randomized trials in glioblastoma. J Neurooncol. 2019Aug;144(1):205-210. doi: 10.1007/s11060-019-03222-y. Epub 2019 Jul 4. PubMedPMID: 31273577.
  • Lee EQ, Chukwueke UN, Hervey-Jumper SL, de Groot JF, Leone JP, Armstrong TS,Chang SM, Arons D, Oliver K, Verble K, Musella A, Willmarth N, Alexander BM,Bates A, Doherty L, Galanis E, Gaffey S, Halkin T, Friday BE, Fouladi M, Lin NU,Macdonald D, Mehta MP, Penas-Prado M, Vogelbaum MA, Sahebjam S, Sandak D, van denBent M, Weller M, Reardon DA, Wen PY. Barriers to Accrual and Enrollment in BrainTumor Trials. Neuro Oncol. 2019 Jun 7. pii: noz104. doi: 10.1093/neuonc/noz104.[Epub ahead of print] PubMed PMID: 31175826.
  • Reblin M, Sahebjam S, Peeri NC, Martinez YC, Thompson Z, Egan KM. MedicalCannabis Use in Glioma Patients Treated at a Comprehensive Cancer Center inFlorida. J Palliat Med. 2019 Oct;22(10):1202-1207. doi: 10.1089/jpm.2018.0528.Epub 2019 May 13. PubMed PMID: 31081711.
  • Tom MC, Varra V, Leyrer CM, Park DY, Chao ST, Yu JS, Suh JH, Reddy CA,Balagamwala EH, Broughman JR, Kotagal KA, Vogelbaum MA, Barnett GH, Ahluwalia MS,Peereboom DM, Prayson RA, Stevens GHJ, Murphy ES. Risk Factors for ProgressionAmong Low-Grade Gliomas After Gross Total Resection and Initial Observation inthe Molecular Era. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1099-1105.doi: 10.1016/j.ijrobp.2019.04.010. Epub 2019 Apr 22. PubMed PMID: 31022510.
  • Ostrom QT, Egan KM, Nabors LB, Gerke T, Thompson RC, Olson JJ, LaRocca R,Chowdhary S, Eckel-Passow JE, Armstrong G, Wiencke JK, Bernstein JL, Claus EB,Il’yasova D, Johansen C, Lachance DH, Lai RK, Merrell RT, Olson SH, Sadetzki S,Schildkraut JM, Shete S, Houlston RS, Jenkins RB, Wrensch MR, Melin B, Amos CI,Huse JT, Barnholtz-Sloan JS, Bondy ML. Glioma risk associated with extent ofestimated European genetic ancestry in African Americans and Hispanics. Int JCancer. 2020 Feb 1;146(3):739-748. doi: 10.1002/ijc.32318. Epub 2019 Apr 22.PubMed PMID: 30963577
  • Kulac I, Tihan T. Pilomyxoid astrocytomas: a short review. Brain TumorPathol. 2019 Apr;36(2):52-55. doi: 10.1007/s10014-019-00343-0. Epub 2019 Apr 3.Review. PubMed PMID: 30945015.
  • Stringfield O, Arrington JA, Johnston SK, Rognin NG, Peeri NC, BalagurunathanY, Jackson PR, Clark-Swanson KR, Swanson KR, Egan KM, Gatenby RA, Raghunand N.Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme.Tomography. 2019 Mar;5(1):135-144. doi: 10.18383/j.tom.2018.00052. PubMed PMID:30854451; PubMed Central PMCID: PMC6403044.
  • Perkins AR, Macaulay RJB, Bui MM, Bridge JA, Etame AB. A Frontal Dural-Based Lesion in a 63-Year Old Male. Brain Pathol. 2019 Mar;29(2):301-302. doi:10.1111/bpa.12682. PubMed PMID: 30821029.
  • Hu LS, Yoon H, Eschbacher JM, Baxter LC, Dueck AC, Nespodzany A, Smith KA,Nakaji P, Xu Y, Wang L, Karis JP, Hawkins-Daarud AJ, Singleton KW, Jackson PR,Anderies BJ, Bendok BR, Zimmerman RS, Quarles C, Porter-Umphrey AB, Mrugala MM,Sharma A, Hoxworth JM, Sattur MG, Sanai N, Koulemberis PE, Krishna C, MitchellJR, Wu T, Tran NL, Swanson KR, Li J. Accurate Patient-Specific Machine LearningModels of Glioblastoma Invasion Using Transfer Learning. AJNR Am J Neuroradiol.2019 Mar;40(3):418-425. doi: 10.3174/ajnr.A5981. Epub 2019 Feb 28. PubMed PMID:30819771; PubMed Central PMCID: PMC6474354.
  • Pires da Silva I, Glitza IC, Haydu LE, Johnpulle R, Banks PD, Grass GD,Goldinger SMA, Smith JL, Everett AS, Koelblinger P, Roberts-Thomson R, MillwardM, Atkinson VG, Guminski A, Kapoor R, Conry RM, Carlino MS, Wang W, ShackletonMJ, Eroglu Z, Lo S, Hong AM, Long GV, Johnson DB, Menzies AM. Incidence, featuresand management of radionecrosis in melanoma patients treated with cerebralradiotherapy and anti-PD-1 antibodies.Pigment Cell Melanoma Res. 2019Jul;32(4):553-563. doi: 10.1111/pcmr.12775. Epub 2019 Mar 3. PubMed PMID:30767428.
  • Eroglu Z, Holmen SL, Chen Q, Khushalani NI, Amaravadi R, Thomas R, Ahmed KA,Tawbi H, Chandra S, Markowitz J, Smalley I, Liu JKC, Chen YA, Najjar YG, KarrethFA, Abate-Daga D, Glitza IC, Sosman JA, Sondak VK, Bosenberg M, Herlyn M, AtkinsMB, Kluger H, Margolin K, Forsyth PA, Davies MA, Smalley KSM. Melanoma centralnervous system metastases: An update to approaches, challenges, andopportunities. Pigment Cell Melanoma Res. 2019 May;32(3):458-469. doi:10.1111/pcmr.12771. Epub 2019 Feb 19. PubMed PMID: 30712316.
  • Galldiks N, Langen KJ, Albert NL, Chamberlain M, Soffietti R, Kim MM, Law I,Le Rhun E, Chang S, Schwarting J, Combs SE, Preusser M, Forsyth P, Pope W, WellerM, Tonn JC. PET imaging in patients with brain metastasis-report of the RANO/PET group. Neuro Oncol. 2019 May 6;21(5):585-595. doi: 10.1093/neuonc/noz003. PubMedPMID: 30615138; PubMed Central PMCID: PMC6502495.
  • Prabhu AH, Kant S, Kesarwani P, Ahmed K, Forsyth P, Nakano I, Chinnaiyan P.Integrative cross-platform analyses identify enhanced heterotrophy as a metabolichallmark in glioblastoma. Neuro Oncol. 2019 Feb 19;21(3):337-347. doi:10.1093/neuonc/noy185. PubMed PMID: 30476237; PubMed Central PMCID: PMC6380409.
  • Apostolatos AH, Apostolatos CA, Ratnayake WS, Neuger A, Sansil S, BourgeoisM, Acevedo-Duncan M. Preclinical testing of5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinomatherapeutic. Anticancer Drugs. 2019 Jan;30(1):65-71. doi:10.1097/CAD.0000000000000694. PubMed PMID: 30204596; PubMed Central PMCID:PMC6287896.
  • Poff A, Koutnik AP, Egan KM, Sahebjam S, D’Agostino D, Kumar NB. Targetingthe Warburg effect for cancer treatment: Ketogenic diets for management ofglioma. Semin Cancer Biol. 2019 Jun;56:135-148. doi:10.1016/j.semcancer.2017.12.011. Epub 2017 Dec 30. Review. PubMed PMID: 29294371.